Vocal cord dysfunction

VOCALCORDDYS

human african trypanosomiasis: A parasitic disorder caused by protozoa of the Trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of Sub-Saharan Africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J38 Cause of death: ICD-10 — J38 2 out of 7 registries used, show all original rules.	8420
4. Check minimum number of events None	8420
5. Include endpoints None	8420
6. Filter based on genotype QC (FinnGen only)	7620

Control definitions (FinnGen only)

Control exclude: ASTHMA_COMORB

Extra metadata

First used in FinnGen datafreeze: DF9
Parent code in ICD-10: J38

NAME	VOCALCORDDYS
CONTROL_EXCLUDE	ASTHMA_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J38
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J38
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vocal cord dysfunction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42520	24121	18181
Only index persons	38879	22738	16141
Unadjusted period prevalence (%)
Whole population	0.61	0.69	0.51
Only index persons	0.74	0.84	0.62
Median age at first event (years)
Whole population	52.45	51.19	53.98
Only index persons	51.86	50.83	53.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7620	4725	2895
Unadjusted period prevalence (%)	1.54	1.68	1.33
Median age at first event (years)	55.58	52.38	60.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7696: Matched controls
67701

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C03DA01

ATC

spironolactone; oral

5.2

320.4

727

1320

N06AX16

ATC

venlafaxine; oral

4.1

317.0

1003

2387

N06AX11

ATC

mirtazapine; oral

2.7

313.1

2431

9953

C10AA01

ATC

simvastatin; oral

2.7

311.7

2306

9211

Z3226

NOMESCO Finland

Physiotherapist

3.2

309.8

1488

4678

C10AA05

ATC

atorvastatin; oral

2.6

308.5

2574

10908

AN1

Coronary angiography

159.7

307.7

461

EP1AE

NOMESCO Finland

Neck ultrasound examination

7.0

307.7

958

1353

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

122.1

307.7

242

H25.1

ICD-10 Finland

Senile nuclear cataract

25.3

307.7

1328

554

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

60.9

307.7

235

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.9

307.7

1413

3684

I48

ICD-10 Finland

Atrial fibrillation and flutter

94.3

307.7

1040

112

A10BK01

ATC

dapagliflozin; oral

112.1

307.7

376

R49.08

ICD-10 Finland

Other specified dysphonia

24.0

307.7

864

355

UDQ02

NOMESCO Finland

Direct laryngoscopy

38.9

307.7

318

G47.3

ICD-10 Finland

Sleep apnoea

3.5

307.7

1745

5260

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

14.3

307.7

357

230

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.7

307.7

877

1803

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

90.6

307.7

483

K78

ICPC

Atrial fibrillation/flutter

20.7

307.7

316

140

H02AB06

ATC

prednisolone; systemic

3.5

307.7

4156

16963

Z50.5

ICD-10 Finland

Speech therapy

26.5

307.7

441

155

N02AX02

ATC

tramadol; systemic, rectal

2.6

307.7

3362

15403

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.4

307.7

2572

5756

AA1AD

NOMESCO Finland

CT of head and brain

4.0

307.7

2068

5726

J38.2

ICD-10 Finland

Nodules of vocal cords

911.5

307.7

833

TFP20

NOMESCO Finland

Cardiodefibrillation

259.1

307.7

311

B01AA03

ATC

warfarin; systemic

7.2

307.7

947

1290

N05AH04

ATC

quetiapine; oral

4.0

307.7

1088

2692

WX408

NOMESCO Finland

General anesthesy, balanced

3.1

307.7

2393

8496

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

14470.9

307.7

3053

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

8.4

307.7

1382

1714

I50.9

ICD-10 Finland

Heart failure, unspecified

17.8

307.7

685

369

I20.99

ICD-10 Finland

Angina pectoris, unspecified

82.0

307.7

296

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

106.8

307.7

457

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.6

307.7

885

1316

A10BH01

ATC

sitagliptin; oral

845.6

307.7

453

UDQ12

NOMESCO Finland

Flexible laryngoscopy

28.2

307.7

2291

1001

UDQ22

NOMESCO Finland

Microlaryngoscopy

102.3

307.7

551

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

177.0

307.7

1119

R4130

NOMESCO Finland

Speech therapy

20.1

307.7

679

324

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

49.3

307.7

1265

269

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

101.1

307.7

234

UDH02

NOMESCO Finland

Rhinopharyngoscopy

5.8

307.7

900

1514

A02BC01

ATC

omeprazole; systemic

2.9

307.7

2166

7966

R49.0

ICD-10 Finland

Dysphonia

10.9

307.7

573

495

A02BC05

ATC

esomeprazole; systemic

3.6

307.7

3876

14886

A02BC02

ATC

pantoprazole; systemic

3.5

307.7

5600

29334

Angiography of the heart and coronary arteries

56.8

307.7

244

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.5

307.7

737

1285

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.2

307.7

1289

2141

R23

ICPC

Voice symptom/complaint

9.7

307.7

507

489

CJB10

NOMESCO Finland

Laser discission of secondary cataract

75.1

307.7

397

XF400

NOMESCO Finland

ECG with 12 standard connections

4.1

307.7

1033

2467

A10BA02

ATC

metformin; oral

35.8

307.7

1484

449

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

649.5

307.7

353

A10BB12

ATC

glimepiride; oral

179.4

307.7

218

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.7

307.7

3997

12693

SPAT1262

SPAT

Handing over of treatment supplies

6.8

307.7

930

1334

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

10.3

307.7

412

369

N03AX16

ATC

[U] pregabalin

3.4

307.7

1885

5864

C01AA05

ATC

digoxin; systemic

19.2

307.7

326

156

J38.3

ICD-10 Finland

Other diseases of vocal cords

1257.2

307.7

1677

R07.4

ICD-10 Finland

Chest pain, unspecified

3.6

307.7

2094

6444

H25.8

ICD-10 Finland

Other senile cataract

60.2

307.7

547

I20.09

ICD-10 Finland

Unstable angina

133.7

307.7

250

104

Kela drug reimbursment

Thyroid insufficiency

4.8

307.7

830

1655

R03BB04

ATC

tiotropium bromide; inhalant

6.6

307.7

1006

1500

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

17.9

307.7

379

195

H26.4

ICD-10 Finland

After-cataract

56.8

307.7

507

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

35.7

307.7

323

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

+∞

307.7

1283

R03AC02

ATC

salbutamol; inhalant

2.9

307.7

4718

23865

J45.9

ICD-10 Finland

Asthma, unspecified

3.9

307.7

1795

4910

C07AB07

ATC

bisoprolol; oral

4.5

307.7

3269

9620

A10AE04

ATC

insulin glargine; parenteral

138.9

307.7

404

DQA10

NOMESCO Finland

Biopsy of larynx

80.2

307.7

340

BAA60

NOMESCO Finland

Total thyroidectomy

10.2

307.7

610

566

J37.0

ICD-10 Finland

Chronic laryngitis

24.7

307.7

1262

533

103

Kela drug reimbursment

Diabetes, insulin-treated

904.0

307.7

1355

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

984.4

307.7

803

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1302

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

43.1

307.7

1694

440

H03AA01

ATC

levothyroxine sodium; systemic

3.0

307.7

2112

7691

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.3

307.7

1147

2151

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

14.6

307.7

874

587

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

78.3

307.7

445

R49.01

ICD-10 Finland

Functional dysphonia

15.0

307.7

888

584

R33

ICD-10 Finland

Retention of urine

23.7

307.7

384

150

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

99.0

307.7

385

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

16.9

307.7

313

169

R49.09

ICD-10 Finland

Unspecified dysphonia

18.2

307.7

311

156

Z96.1

ICD-10 Finland

Presence of intraocular lens

11.9

307.7

704

570

R13

ICD-10 Finland

Dysphagia

7.7

307.7

956

1226

C01DA14

ATC

isosorbide mononitrate; oral

26.5

307.7

782

288

A10AC01

ATC

insulin (human); parenteral

19.9

307.7

297

136

WX100

NOMESCO Finland

Conjunctival surface anesthesia

21.6

307.7

681

303

C03CA01

ATC

furosemide; systemic

5.8

307.7

1850

3521

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

9.8

307.7

493

470

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

97.8

307.7

480

F32.9

ICD-10 Finland

Depressive episode, unspecified

6.8

307.7

804

1143

B01AF02

ATC

apixaban; oral

7.6

307.7

681

849

A10BK03

ATC

empagliflozin; oral

172.8

307.7

479

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

307.7

1725

5710

Z01.8

ICD-10 Finland

Other specified special examinations

3.2

307.7

1988

6707

J38.7

ICD-10 Finland

Other diseases of larynx

249.2

307.7

834

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

57.1

307.7

365

R06.0

ICD-10 Finland

Dyspnoea

4.9

307.7

2525

6086

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

733

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.2

307.7

1554

3114

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

12.6

307.7

375

274

B01AC04

ATC

clopidogrel; oral

12.4

307.7

892

708

E11

ICD-10 Finland

Type 2 diabetes mellitus

24.1

307.7

760

306

J38.5

ICD-10 Finland

Laryngeal spasm

447.3

307.7

388

I50.0

ICD-10 Finland

Congestive heart failure

24.2

307.7

315

119

R06.5

ICD-10 Finland

Mouth breathing

8.0

307.7

629

749

215

Kela drug reimbursment

Diabetes, non-insulin-treated

6630.1

307.7

1282

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

38.7

307.7

280

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

20.7

307.7

331

147

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

12.3

307.7

1051

861

207

Kela drug reimbursment

Chronic arrhythmias

132.9

307.7

775

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

53.2

307.7

793

146

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

17.0

307.7

334

180

A02BC03

ATC

lansoprazole; oral

3.0

307.7

2284

8446

J38.4

ICD-10 Finland

Oedema of larynx

688.0

307.7

710

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.6

307.7

916

1367

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

307.7

2509

9834

I25.1

ICD-10 Finland

Atherosclerotic heart disease

98.6

307.7

1155

121

A10AB05

ATC

insulin aspart; parenteral

53.5

307.7

332

T90

ICPC

Diabetes non-insulin dependent

21.0

307.7

1345

675

R02

ICPC

Shortness of breath/dyspnoea

4.5

307.7

1161

2597

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.5

307.7

1158

2094

E66.8

ICD-10 Finland

Other obesity

15.2

307.5

294

176

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.5

307.1

1244

3513

E66.01

ICD-10 Finland

Obesity due to excess calories

6.4

304.2

551

804

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.8

300.1

755

1497

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

300.0

1830

6587

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2680.2

299.2

302

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

22.7

297.6

238

N05BA04

ATC

oxazepam; oral

2.9

297.5

1825

6586

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.4

296.1

468

588

XF402

NOMESCO Finland

ECG with work load test

5.3

295.6

652

1152

I25

ICD-10 Finland

Chronic ischaemic heart disease

46.8

295.0

192

N06AB04

ATC

citalopram; systemic

3.3

294.8

1375

4237

WX734

NOMESCO Finland

JET-ventilation

148.3

293.4

165

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

13.6

293.1

298

200

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

292.6

293

ZXA10

NOMESCO Finland

Bilateral

3.3

291.0

1337

4080

N06AX21

ATC

duloxetine; oral

4.1

290.9

898

2093

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

288.2

3887

20369

C10AX09

ATC

ezetimibe; oral

3.8

286.0

992

2515

ZXE00

NOMESCO Finland

One hour or less

2.4

285.6

3017

14178

N05CF01

ATC

zopiclone; oral

2.6

285.0

2248

9209

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

17.9

284.5

251

127

N03AX12

ATC

[U] gabapentin; oral

3.4

283.3

1224

3591

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.1

282.8

655

1208

I48.1

ICD-10 Finland

Persistent atrial fibrillation

120.5

281.7

161

OAB50, ,

SPAT

7.2

281.4

456

589

RL210, ,

NOMESCO Finland

42.7

278.8

185

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

277.5

278

C09AA05

ATC

ramipril; oral

3.2

271.1

1278

3950

UJF32

NOMESCO Finland

Coloscopy

2.8

269.6

1791

6705

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

267.7

2912

13777

C08CA01

ATC

amlodipine; oral

2.5

264.2

2362

10215

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.9

264.2

1589

5637

P01BA02

ATC

hydroxychloroquine; oral

6.1

262.1

493

746

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

260.4

261

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

17.2

258.3

232

122

R03DC03

ATC

montelukast; oral

2.8

258.0

1561

5549

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

13.0

257.6

268

187

GD1AD

NOMESCO Finland

Thorax CT examination

5.1

257.1

591

1081

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

256.6

1583

5685

WX892

NOMESCO Finland

Monitored bed care

5.7

256.3

522

854

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

119.0

255.1

146

T36

ICD-10 Finland

Poisoning by systemic antibiotics

15.8

252.3

236

135

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

5.5

252.2

534

906

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

26.8

252.0

190

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

30.3

251.2

182

R03AK08

ATC

formoterol and beclometasone; inhalant

5.6

249.9

521

871

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

12.1

249.0

271

204

201

Kela drug reimbursment

Chronic cardiac insufficiency

16.8

247.8

225

121

L28

ICPC

Limited function/disability (L)

3.1

247.6

1226

3888

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

38.7

247.5

168

A10BJ06

ATC

semaglutide; parenteral

+∞

246.4

247

R49.03

ICD-10 Finland

Atrophic dysphonia

15.1

245.2

235

141

R03BA08

ATC

ciclesonide; inhalant

3.6

245.0

908

2399

C07AB02

ATC

metoprolol; systemic

3.3

244.4

1062

3111

J01MA12

ATC

levofloxacin; systemic

2.9

243.6

1385

4747

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

243.3

2659

12498

XF404

NOMESCO Finland

Ambulatory ECG

5.6

242.2

505

844

ZXC10

NOMESCO Finland

Use of laser

7.9

241.8

359

418

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

9.1

240.5

317

H02AB04

ATC

methylprednisolone; systemic

3.0

237.2

1226

3979

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

74.8

235.9

142

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.0

234.7

342

389

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

232.3

930

2582

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.4

232.3

495

844

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

93.7

232.1

136

I50.1

ICD-10 Finland

Left ventricular failure

27.0

231.5

174

A28

ICPC

Limited function/disability NOS

3.3

231.0

984

2842

I25.2

ICD-10 Finland

Old myocardial infarction

541.0

230.4

239

R5140

NOMESCO Finland

Monitoring the use of the aid

3.8

229.7

798

2014

J04.0

ICD-10 Finland

Acute laryngitis

4.9

228.5

550

1045

R42

ICD-10 Finland

Dizziness and giddiness

2.6

228.2

1639

6327

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

227.8

2858

14151

R03BA05

ATC

fluticasone; inhalant

2.7

227.7

1567

5921

I47.1

ICD-10 Finland

Supraventricular tachycardia

17.7

225.7

200

102

A02BC04

ATC

rabeprazole; oral

3.6

224.5

848

2264

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.8

223.8

551

1067

N02BE01

ATC

paracetamol; systemic, rectal

3.1

223.6

6806

48323

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.3

222.9

628

1357

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

6.4

222.8

397

567

H02AB07

ATC

prednisone; oral

3.2

220.8

1039

3185

A02BA02

ATC

ranitidine; systemic

2.8

220.8

1343

4755

R53

ICD-10 Finland

Malaise and fatigue

2.5

218.8

1808

7447

T89

ICPC

Diabetes insulin dependent

69.5

217.1

132

J45.1

ICD-10 Finland

Nonallergic asthma

4.2

216.7

633

1406

N06AB10

ATC

escitalopram; oral

2.7

215.9

1381

5015

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

11.3

215.9

244

195

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.4

215.3

598

1277

WX872

NOMESCO Finland

Intensive care

8.8

212.8

288

298

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

496.5

211.4

220

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.0

210.8

494

916

J01FA06

ATC

roxithromycin; oral

2.1

210.6

3050

15872

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

209.6

3262

17441

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

209.4

3208

17047

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

209.4

1871

7967

S18

ICPC

Laceration/cut

2.1

209.1

3431

18710

R51.80

ICD-10 Finland

Headache

2.8

207.8

1246

4368

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

207.2

843

2358

J01FF01

ATC

clindamycin; systemic

2.3

206.7

2024

8967

A10BJ02

ATC

liraglutide; parenteral

40.9

204.5

137

WX002

NOMESCO Finland

Sedation and analgesia

2.7

203.9

1298

4691

J01DB01

ATC

cefalexin; oral

2.5

202.5

6308

43788

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

10.1

201.4

246

221

205

Kela drug reimbursment

Chronic hypertension

2.7

200.3

1274

4599

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

8.8

200.0

269

276

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

33.9

199.4

140

A07EC02

ATC

mesalazine; oral, rectal

10.5

199.0

236

203

Z3231

NOMESCO Finland

Registered nurse

2.4

198.8

1802

7701

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

198.1

1894

8284

N06AA09

ATC

amitriptyline; systemic

3.9

197.6

638

1524

J01AA02

ATC

doxycycline; systemic

2.3

197.6

5970

40625

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.7

197.5

296

348

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

19.1

196.4

168

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

196.2

3084

16443

L04AX01

ATC

azathioprine; systemic

11.3

195.9

221

176

XCK10

NOMESCO Finland

Photography of fundus of eye

5.1

194.8

447

813

N05BA01

ATC

diazepam; systemic, rectal

3.3

194.5

821

2347

ZXD05

NOMESCO Finland

Urgent procedure

2.3

194.5

2046

9311

XG474

NOMESCO Finland

Exhalation nntrogen oxide

6.8

193.6

325

435

M79.6

ICD-10 Finland

Pain in limb

2.1

193.1

3316

18238

A10AE05

ATC

insulin detemir; parenteral

362.9

192.0

202

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.4

191.8

412

706

XG410

NOMESCO Finland

Flow-volume spirometry

6.1

190.6

357

536

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

190.2

191

N05AH03

ATC

olanzapine; systemic

7.7

190.1

285

335

R96

ICPC

Asthma

3.3

188.6

811

2344

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

188.2

189

UJF30

NOMESCO Finland

Ileoscopy through colon

3.4

188.2

752

2075

F29

ICD-10 Finland

Unspecified nonorganic psychosis

53.1

187.4

119

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.3

186.5

782

2224

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

186.5

1656

6990

I50

ICD-10 Finland

Heart failure

35.0

185.3

129

L04AX03

ATC

methotrexate; systemic

4.1

185.1

565

1294

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

184.5

4108

24650

A10BH05

ATC

linagliptin; oral

572.9

184.3

191

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.2

183.7

1998

9188

SPAT1263

SPAT

Sampling

2.1

183.1

2809

14752

UKC02

NOMESCO Finland

Cystoscopy

2.9

182.8

1008

3364

A07EA06

ATC

budesonide; oral, local oral

11.2

181.9

207

167

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

181.4

729

2017

R04.2

ICD-10 Finland

Haemoptysis

7.0

181.3

296

384

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

837.3

181.1

186

A10AB04

ATC

insulin lispro; parenteral

61.9

179.3

111

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.1

178.9

287

365

N05AX12

ATC

aripiprazole; systemic

15.8

178.8

167

A06AD11

ATC

lactulose; oral

3.0

177.9

904

2880

N06AB03

ATC

fluoxetine; oral

3.3

175.8

743

2121

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

29.3

175.0

128

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.3

174.7

723

2037

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

15.2

174.4

166

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

9.7

173.9

218

203

I48.2

ICD-10 Finland

Chronic atrial fibrillation

280.1

173.7

185

E66.00

ICD-10 Finland

Metabolic syndrome

7.4

173.6

271

334

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

22.9

173.5

138

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.5

172.3

265

321

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

172.1

2035

9640

M54.5

ICD-10 Finland

Low back pain

2.0

171.8

2709

14296

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

13.6

171.5

173

114

R03BA02

ATC

budesonide; inhalant

2.4

171.1

1450

5971

UJC01

NOMESCO Finland

Scopy of lower throat

12.3

170.7

183

134

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

170.2

171

R05

ICD-10 Finland

Cough

2.2

168.7

1755

7888

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

168.4

3040

16797

N02AA05

ATC

oxycodone; systemic

2.5

167.9

1260

4903

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.5

167.8

346

570

TFP34

NOMESCO Finland

Electrophysiological investigation

22.6

167.8

134

J01MA02

ATC

ciprofloxacin; systemic

2.0

167.6

2658

14027

XG466

NOMESCO Finland

Sleep oxymetry

9.6

167.6

212

200

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.2

166.3

482

1060

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

166.2

167

L17

ICPC

Foot/toe symptom/complaint

2.1

164.9

2155

10582

N06AB06

ATC

sertraline; oral

3.4

164.8

668

1855

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

164.8

652

1783

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

163.8

631

1696

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

163.6

1342

5437

GBB00

NOMESCO Finland

Tracheostomy

13.1

163.0

168

115

N05CD07

ATC

temazepam; oral

3.4

162.3

646

1773

S97

ICPC

Chronic ulcer skin

5.3

162.1

348

595

R4110

NOMESCO Finland

Physiotherapy

2.1

162.0

1958

9323

Z2446

NOMESCO Finland

Social worker

4.5

161.5

422

855

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

160.9

912

3078

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.9

160.4

865

2842

SPAT1310

SPAT

Counselling related to known health issue

2.1

160.4

2036

9873

ZXA05

NOMESCO Finland

Left side

2.3

160.1

1606

7093

A07AA02

ATC

nystatin; oral

4.1

159.9

486

1107

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

6.1

159.4

297

443

SPAT1301

SPAT

No procedures

2.1

159.2

1964

9416

N03AX09

ATC

lamotrigine; oral

6.3

158.8

286

412

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.9

157.7

823

2654

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.2

157.1

460

1019

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

156.6

2349

12095

A10BB01

ATC

glibenclamide; oral

82.8

156.4

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

155.8

790

2506

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

155.7

1045

3844

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

154.6

664

1910

R01AD09

ATC

mometasone; nasal

1.9

154.4

3599

21476

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

154.1

1012

3682

B01AB05

ATC

enoxaparin; parenteral

2.1

153.5

2100

10445

K90

ICPC

Stroke/cerebrovascular accident

20.9

152.9

126

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

24.1

152.7

119

R03AC13

ATC

formoterol; inhalant

4.2

152.4

439

960

E66.9

ICD-10 Finland

Obesity, unspecified

11.2

152.4

173

139

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.4

152.3

411

854

SPAT1254

SPAT

Administration of medicine

2.8

151.0

836

2782

J45

ICD-10 Finland

Asthma

2.8

150.9

874

2980

C01BC04

ATC

flecainide; systemic

15.5

150.8

142

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

27.8

150.6

112

M48.0

ICD-10 Finland

Spinal stenosis

3.0

150.4

772

2464

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.8

150.1

492

1183

WZC30

NOMESCO Finland

Teaching

2.4

150.1

1213

4866

N03AE01

ATC

clonazepam; systemic

4.6

149.9

384

765

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

6.8

149.9

249

329

R60.0

ICD-10 Finland

Localized oedema

2.9

149.6

806

2642

A10AB01

ATC

insulin (human); parenteral

50.3

149.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.5

149.1

394

805

A11

ICPC

Chest pain NOS

3.5

148.7

563

1494

K77

ICPC

Heart failure

42.0

148.6

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

148.2

149

R03BA01

ATC

beclometasone; inhalant

2.5

148.0

1075

4102

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

147.2

148

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

147.2

580

1579

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

147.1

1824

8725

L01BA01

ATC

methotrexate; systemic

9.0

147.1

195

196

SPAT1097

SPAT

Recording of ECG

2.8

146.9

819

2734

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.2

146.6

428

945

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

146.6

688

2085

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

12.2

146.4

157

115

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

146.3

867

2989

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

146.2

147

ZY010

NOMESCO Finland

Hospital outpatient

5.7

145.9

291

464

RP210, ,

NOMESCO Finland

51.7

145.6

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

145.3

1095

4249

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1354.3

145.1

148

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

33.7

145.1

102

G44.2

ICD-10 Finland

Tension-type headache

2.5

144.6

1054

4026

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

7.0

144.2

234

301

SPAT1153

SPAT

Removal of sutures

2.0

143.5

2082

10537

J01DA01

ATC

[U] cefalexin

1.9

143.4

4492

29162

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

143.1

762

2480

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

34.3

142.9

100

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

141.7

790

2635

A04

ICPC

Weakness/tiredness general

2.5

141.7

1034

3950

F10.09

ICD-10 Finland

Alcohol intoxication UNS

60.2

141.5

K51.5

ICD-10 Finland

Left sided colitis

75.6

141.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

141.0

963

3563

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

140.8

2771

15528

R07.0

ICD-10 Finland

Pain in throat

2.9

140.6

728

2332

N05AA02

ATC

levomepromazine; systemic

9.9

140.5

173

157

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.9

139.3

229

299

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

139.2

1294

5504

ZXA00

NOMESCO Finland

Right side

2.1

139.1

1638

7662

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.1

138.9

314

562

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.4

138.7

292

490

P76

ICPC

Depressive disorder

4.4

138.6

372

769

N06AX12

ATC

bupropion; oral

4.1

138.5

407

903

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

639.7

138.3

143

J46

ICD-10 Finland

Status asthmaticus

6.2

138.0

250

362

UJD02

NOMESCO Finland

Gastroscopy

4.7

137.7

346

678

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

18.2

137.5

120

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.9

137.0

722

2334

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

136.6

1720

8245

A01

ICPC

Pain general/multiple sites

3.0

136.6

676

2110

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.0

136.5

257

387

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

135.7

2560

14112

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.1

135.4

218

278

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

135.1

967

3655

N06AX26

ATC

vortioxetine; oral

3.8

134.5

438

1047

R03AC03

ATC

terbutaline; inhalant

2.4

134.3

1064

4215

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

416.4

133.7

140

SPAT1216

SPAT

Assessment of functional ability

2.7

133.6

836

2958

M04AA01

ATC

allopurinol; systemic

3.2

133.2

596

1753

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

133.0

1252

5345

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

14.3

132.7

130

H26.02

ICD-10 Finland

Presenil cataract

19.8

132.0

111

R95

ICPC

Chron obstructive pulmonary disease

7.0

131.9

215

278

J45.8

ICD-10 Finland

Mixed asthma

5.4

131.7

276

461

C07AA05

ATC

propranolol; systemic

2.2

131.6

1392

6231

Z2221

NOMESCO Finland

Medical doctor

2.0

131.2

1873

9380

G04CA02

ATC

tamsulosin; oral

2.2

131.1

1280

5546

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.1

130.9

141

104

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

32.8

129.9

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.1

129.7

587

1738

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

40.7

129.7

WX402

NOMESCO Finland

General anaesthesia

2.0

129.5

1730

8454

A11CC03

ATC

alfacalcidol; systemic

8.4

129.2

180

193

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

128.9

2082

10869

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.6

128.6

469

1212

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

128.3

613

1873

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

128.3

129

M25.5

ICD-10 Finland

Pain in joint

1.9

128.2

2454

13541

L03

ICPC

Low back symptom/complaint

1.9

127.0

2063

10781

R01AD08

ATC

fluticasone; nasal

1.9

126.9

2225

11926

K76

ICPC

Ischaemic heart dis without angina

38.2

126.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

297.6

126.3

134

A10AE06

ATC

insulin degludec; parenteral

1155.0

126.2

129

R03AC12

ATC

salmeterol; inhalant

4.3

125.8

345

725

R06AE07

ATC

cetirizine; oral

1.8

125.7

3317

20154

R07.3

ICD-10 Finland

Other chest pain

2.8

125.2

682

2242

SPAT1229

SPAT

Assessment of need for aid

3.8

125.1

409

980

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

9.0

124.9

165

I49.5

ICD-10 Finland

Sick sinus syndrome

10.4

124.8

148

127

B01AC24

ATC

ticagrelor; oral

173.9

124.3

136

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.0

124.2

286

520

J01FA10

ATC

azithromycin; systemic

1.8

123.8

4457

29583

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.5

123.5

467

1235

R50.9

ICD-10 Finland

Fever, unspecified

2.3

123.5

1058

4330

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

123.3

5264

36720

CL2S4, ,

SPAT

47.4

123.1

PD5AD

NOMESCO Finland

CT of aorta

9.1

123.0

161

159

N05AB03

ATC

perphenazine; systemic, rectal

11.0

122.9

141

115

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

122.4

861

3221

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.5

122.0

462

1223

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

121.6

1148

4893

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.3

121.4

337

715

A07EC01

ATC

sulfasalazine; oral, rectal

3.9

121.2

391

928

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

121.1

455

1198

IGY02

NOMESCO Finland

Psychiatric monitoring contact

10.8

120.8

140

116

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

120.7

589

1820

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

120.6

1313

5925

J02AC01

ATC

fluconazole; systemic

1.8

120.0

3074

18445

R55

ICD-10 Finland

Syncope and collapse

2.8

119.6

653

2147

N05AF03

ATC

chlorprothixene; systemic

20.5

119.4

N02BF01

ATC

gabapentin; oral

2.7

119.4

710

2442

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.8

119.4

393

946

R05FB02

ATC

cough suppressants and expectorants; systemic

1.8

119.1

2547

14477

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.4

119.0

458

1225

N02BF02

ATC

pregabalin; oral

3.4

118.5

473

1295

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

8.4

118.3

165

177

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

41.3

118.1

R5110, ,

SPAT

3.1

117.6

550

1658

E0000UV, ,

ATC

1.8

117.3

3001

17965

R03AK11

ATC

formoterol and fluticasone; inhalant

5.2

117.0

254

438

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.1

116.9

215

316

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

116.6

1335

6135

WX722

NOMESCO Finland

PEEP

5.0

116.5

269

490

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

14.3

116.4

114

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

7.3

116.3

181

222

SPAT1058

SPAT

PEF monitoring instruction

3.2

115.9

515

1506

R04.0

ICD-10 Finland

Epistaxis

3.4

115.9

449

1206

J01FA09

ATC

clarithromycin; systemic

1.8

115.5

2374

13305

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

115.2

2468

14003

Z71.8

ICD-10 Finland

Other specified counselling

1.8

114.8

2392

13456

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

8.3

114.8

161

174

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.8

114.6

647

2164

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

114.6

1943

10245

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

10.5

114.4

135

115

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

114.3

115

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.4

114.3

202

285

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.0

114.3

151

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

114.0

593

1898

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

11.9

113.9

124

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.8

113.7

651

2194

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

113.4

631

2094

UJC12

NOMESCO Finland

Flexible oesophagoscopy

12.8

113.4

118

XQ800

NOMESCO Finland

Prick test

2.8

113.3

640

2141

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

113.3

759

2769

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

62.1

113.0

XKD00

NOMESCO Finland

Uroflowmetry

2.4

112.9

878

3435

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

112.3

1000

4150

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

112.1

906

3605

J01CA04

ATC

amoxicillin; systemic

1.9

112.0

6115

45224

C09AA02

ATC

enalapril; systemic

2.3

111.6

933

3768

J20

ICD-10 Finland

Acute bronchitis

2.5

111.5

801

3020

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

111.1

1050

4466

B01AC06

ATC

acetylsalicylic acid; oral

30.9

111.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

13.3

110.6

113

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

5.7

110.4

220

350

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.7

110.4

219

347

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.6

110.3

392

994

JN4AD

NOMESCO Finland

Body CT examination

2.5

110.1

787

2959

K84

ICPC

Heart disease other

10.9

109.7

126

103

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.5

109.5

285

574

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

9.7

109.4

136

125

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.5

109.4

191

266

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

4.8

109.1

263

497

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

109.1

614

2049

P03

ICPC

Feeling depressed

2.9

108.8

577

1865

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.1

108.7

500

1491

R05

ICPC

Cough

1.9

108.6

1786

9300

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

108.5

1792

9343

J01MA14

ATC

moxifloxacin; systemic

2.7

108.2

646

2223

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.5

107.7

402

1053

C01BD01

ATC

amiodarone; systemic

498.4

107.6

112

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

498.4

107.6

112

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

11.2

107.4

121

C09CA01

ATC

losartan; oral

2.0

107.2

1488

7313

SPAT1260

SPAT

Consultation of another employee

2.2

107.0

1052

4543

P01AB01

ATC

metronidazole; oral, rectal

1.7

107.0

2839

17057

SPAT1325

SPAT

Vaccination

1.8

106.8

2020

10986

I20.00

ICD-10 Finland

Unstable angina

255.8

106.6

114

PD5BD

NOMESCO Finland

Extensive CT of aorta

11.9

106.6

116

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

106.5

913

3723

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

106.4

531

1659

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

14.9

106.3

102

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

106.0

591

1962

M01AH01

ATC

celecoxib; oral

2.1

105.6

1213

5565

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

105.4

763

2884

UDC00

NOMESCO Finland

Ear microscopy

2.9

105.2

559

1808

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

328.2

105.1

111

M05BA04

ATC

alendronic acid; oral

3.2

104.9

440

1241

R31

ICD-10 Finland

Unspecified haematuria

2.8

104.8

588

1958

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

104.6

3903

25661

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.7

104.6

206

324

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

104.6

450

1289

C08CA13

ATC

lercanidipine; oral

2.5

104.5

757

2862

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.8

104.5

564

1840

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.0

104.2

516

1605

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

104.0

782

3007

M79.7

ICD-10 Finland

Fibromyalgia

4.9

104.0

245

454

SPAT1240

SPAT

Therapeutic discussion

2.8

103.7

592

1989

R01AD12

ATC

fluticasone furoate; nasal

1.8

103.6

2493

14540

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.5

103.3

726

2705

F34.1

ICD-10 Finland

Dysthymia

6.8

103.2

171

225

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

24.5

103.2

R03DA04

ATC

theophylline; systemic, rectal

3.7

103.0

347

848

N05CF02

ATC

zolpidem; oral

2.1

102.9

1167

5323

G04BD12

ATC

mirabegron; oral

2.5

102.8

741

2794

B01AC07

ATC

dipyridamole; systemic

7.8

102.7

151

173

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

102.7

728

2724

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

935.6

102.4

105

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

10.9

102.3

118

M01AX17

ATC

nimesulide; oral

1.9

102.3

1532

7714

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

102.0

657

2347

R21

ICPC

Throat symptom/complaint

1.9

101.9

1682

8744

R4190

NOMESCO Finland

Nutritional therapy

4.0

101.6

304

682

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

3.3

101.2

413

1145

R52.9

ICD-10 Finland

Pain, unspecified

2.5

101.0

740

2811

UJC02

NOMESCO Finland

Rigid oesophagoscopy

10.0

100.8

123

110

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

12.6

100.8

106

B01AF03

ATC

edoxaban; oral

17.6

100.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

100.4

2605

15487

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

100.4

101

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

6.0

100.2

189

285

L88

ICPC

Rheumatoid/seropositive arthritis

5.5

100.0

205

335

I42.0

ICD-10 Finland

Dilated cardiomyopathy

14.7

99.5

C08DB01

ATC

diltiazem; oral

5.3

99.4

214

366

AN4

Balloon angioplasty and drug eluding stent

+∞

99.4

100

K30

ICD-10 Finland

Functional dyspepsia

2.3

99.3

823

3303

N07BB01

ATC

disulfiram; oral

5.7

99.3

195

306

F61.0

ICD-10 Finland

Mixed personality disorders

27.4

99.0

N05BA12

ATC

alprazolam; oral

2.7

99.0

577

1959

M03BX02

ATC

tizanidine; oral

1.7

98.9

4615

31969

P20

ICPC

Memory disturbance

2.5

98.7

669

2448

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.3

98.6

267

555

R06.2

ICD-10 Finland

Wheezing

3.5

98.4

357

917

J31.0

ICD-10 Finland

Chronic rhinitis

2.5

98.1

681

2521

B01AF01

ATC

rivaroxaban; oral

2.6

98.0

640

2300

SPAT1104

SPAT

Monitoring of emergency patient

3.4

98.0

385

1042

C10AA04

ATC

fluvastatin; oral

3.3

97.9

389

1060

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

97.9

642

2312

A46

ICD-10 Finland

Erysipelas

2.4

97.7

783

3095

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.4

97.7

257

522

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.3

97.6

796

3171

XF600

NOMESCO Finland

Bloodpressure measurement

3.4

97.5

372

988

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

97.4

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.1

97.3

179

263

L01

ICPC

Neck symptom/complaint

2.0

97.3

1205

5670

N04BC05

ATC

pramipexole; oral

3.0

97.2

476

1470

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

11.3

97.0

109

A01AB09

ATC

miconazole; local oral

2.7

97.0

584

2015

GD6AD

NOMESCO Finland

CT of chest and neck

14.0

96.9

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.4

96.9

169

235

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

96.7

377

1015

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

96.5

1403

6980

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

+∞

96.4

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

11.0

96.4

110

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.6

96.2

192

306

F10.20

ICD-10 Finland

Alcohol dependence currently independent

21.7

96.2

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

136.3

96.0

107

F10.25

ICD-10 Finland

Alcohol dependence continuous use

29.6

95.9

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.4

95.7

200

333

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

12.5

95.6

101

R11

ICD-10 Finland

Nausea and vomiting

2.8

95.5

538

1793

C10AA07

ATC

rosuvastatin; oral

1.8

95.3

2049

11515

N17

ICPC

Vertigo/dizziness

2.3

95.3

795

3197

H25.0

ICD-10 Finland

Senile incipient cataract

3.8

95.1

311

744

S29

ICPC

Skin symptom/complaint other

1.9

94.2

1413

7097

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

93.8

1726

9254

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

93.7

788

3179

SPAT1053

SPAT

Memory test

2.6

93.6

619

2237

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

93.4

762

3033

J38.6

ICD-10 Finland

Stenosis of larynx

+∞

93.4

R4120

NOMESCO Finland

Occupational therapy

3.3

93.3

387

1083

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

93.1

904

3872

C07AA07

ATC

sotalol; systemic

7.4

92.9

143

173

K80

ICPC

Cardiac arrhythmia NOS

2.8

92.7

493

1593

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.4

91.7

704

2727

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.9

91.6

467

1474

F32.1

ICD-10 Finland

Moderate depressive episode

3.5

91.6

345

908

I20.01

ICD-10 Finland

Unstable angina

836.2

91.5

AN2

Balloon angioplasty, including several vessels

+∞

91.4

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

91.1

553

1915

A12BA01

ATC

potassium chloride; oral

6.5

90.9

158

219

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

90.8

342

900

R03BB01

ATC

ipratropium bromide; inhalant

4.2

90.8

255

545

M02AA07

ATC

piroxicam; topical

1.7

90.6

2317

13637

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

90.4

860

3651

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

90.2

579

2061

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.6

90.1

229

452

N05BE01

ATC

buspirone; oral

7.2

89.9

142

177

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.1

89.8

405

1192

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.1

89.6

259

566

R35

ICD-10 Finland

Polyuria

3.0

89.4

435

1338

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.5

89.3

323

828

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.9

89.2

208

382

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

12.5

89.0

R06.1

ICD-10 Finland

Stridor

17.8

88.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

88.3

1834

10168

K07

ICPC

Swollen ankles/oedema

4.3

88.1

244

516

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.7

87.9

173

272

N06AX03

ATC

mianserin; oral

4.3

87.9

240

502

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.3

87.7

243

514

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

11.5

87.4

Z01.9

ICD-10 Finland

Special examination, unspecified

3.0

87.3

421

1288

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

87.2

1677

9084

Z72.0

ICD-10 Finland

Tobacco use

5.8

86.8

169

263

ZX120

NOMESCO Finland

Intravenous

2.5

86.6

579

2101

N03AG01

ATC

valproic acid; systemic, rectal

3.8

86.5

286

689

C02AC05

ATC

moxonidine; oral

4.9

86.5

203

375

D21

ICPC

Swallowing problem

7.8

86.1

127

146

A03FA02

ATC

cisapride; oral, rectal

2.9

86.0

443

1406

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

85.9

1804

10022

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

85.6

947

4260

Z02.7

ICD-10 Finland

Issue of medical certificate

2.9

85.5

448

1435

ZY000

NOMESCO Finland

Hospital inpatient

20.3

85.4

SPAT1255

SPAT

Intravenous administration of medicine

3.1

85.3

392

1166

M10.9

ICD-10 Finland

Gout, unspecified

3.5

85.1

307

785

R52.2

ICD-10 Finland

Other chronic pain

4.0

85.0

257

581

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

84.9

1560

8328

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

84.8

462

1511

J34.2

ICD-10 Finland

Deviated nasal septum

3.0

84.7

405

1233

A10AA02, ,

ATC

773.1

84.5

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

84.5

381

1121

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

84.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

84.4

3912

26595

L04AA13

ATC

[U] leflunomide

8.0

83.8

120

133

C03AA03

ATC

hydrochlorothiazide; oral

3.0

83.8

406

1245

R49.1

ICD-10 Finland

Aphonia

14.3

83.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

83.7

489

1659

P06

ICPC

Sleep disturbance

2.2

83.6

816

3495

Z2445

NOMESCO Finland

Psychologist

5.0

83.5

189

338

A10BJ05

ATC

dulaglutide; parenteral

+∞

83.4

F41.09

ICD-10 Finland

UNS Panic Syndrome

6.6

83.3

141

190

B01AE07

ATC

dabigatran etexilate; oral

6.0

83.1

155

231

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

47.8

83.1

PA6AD

NOMESCO Finland

CT of neck arteries

4.2

82.8

231

491

I95.1

ICD-10 Finland

Orthostatic hypotension

5.5

82.8

169

275

R1260

NOMESCO Finland

Evaluation of communicative skills

8.2

82.4

116

126

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

14.5

82.3

R4110, ,

SPAT

2.1

81.9

878

3898

1420

FHL

Laryngomicroscopy

8.9

81.7

108

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

81.6

318

855

M79.1

ICD-10 Finland

Myalgia

2.0

81.3

1042

4939

250, ,

Kela drug reimbursment

376.2

80.9

ZX114

NOMESCO Finland

Intramuscular

5.9

80.7

154

235

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

6.0

80.6

151

226

S06.0

ICD-10 Finland

Concussion

2.3

80.5

651

2575

XKD06

NOMESCO Finland

Physiologic investigation of micturition

5.0

80.3

182

326

N05AX08

ATC

risperidone; systemic

3.4

80.1

304

804

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.5

80.0

122

146

R01AD58

ATC

fluticasone, combinations; nasal

1.7

79.6

1942

11212

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

10.6

79.6

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.0

79.5

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

4.9

79.5

185

339

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

9.4

79.3

101

A99

ICPC

Disease/condition unspecnature/site

2.3

79.3

662

2655

SPAT1234

SPAT

Support of social functional capacity

4.3

79.1

215

448

R29

ICPC

Respiratory symptom/complaint other

2.6

78.8

493

1730

A29

ICPC

General symptom/complaint other

2.1

78.7

814

3562

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

78.5

350

1022

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

6.8

78.5

130

171

106

Kela drug reimbursment

Hypoparathyroidism

15.8

78.5

160

Kela drug reimbursment

exenatide

+∞

78.5

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

78.5

Z00.0

ICD-10 Finland

General medical examination

1.9

78.3

1271

6512

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

5.3

78.2

165

277

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

78.2

2153

12823

C08DA01

ATC

verapamil; systemic

4.4

77.7

206

421

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.7

77.6

264

649

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

77.5

R06AX27

ATC

desloratadine; oral

1.7

77.4

2199

13197

F10.24

ICD-10 Finland

Alcohol depence active use

27.1

77.3

C10AA03

ATC

pravastatin; oral

3.2

77.2

329

935

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.5

77.1

280

719

N07BA03

ATC

varenicline; oral

3.1

77.0

349

1029

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

76.8

1702

9556

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

76.8

2748

17449

X58

ICD-10 Finland

Exposure to other specified factors

1.9

76.7

1070

5214

M54.2

ICD-10 Finland

Cervicalgia

2.4

76.7

596

2315

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.9

76.5

238

549

XF640, ,

NOMESCO Finland

6.1

76.4

139

202

D07AC01

ATC

betamethasone; topical

1.6

76.3

2423

14939

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.6

76.3

154

248

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

76.1

3211

21173

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.6

76.1

129

174

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

76.0

446

1515

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

353.7

76.0

N30.0

ICD-10 Finland

Acute cystitis

1.9

75.8

1095

5397

C08CA05

ATC

nifedipine; systemic

3.3

75.8

308

850

D01

ICPC

Abdominal pain/cramps general

2.1

75.8

840

3771

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

44.3

75.7

M01AE02

ATC

naproxen; oral, rectal

1.6

75.5

4019

27913

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

13.9

75.4

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

75.4

431

1445

A12AA04

ATC

calcium carbonate; oral

10.4

75.3

UGB02

NOMESCO Finland

Tracheoscopy

27.6

75.0

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.7

75.0

254

622

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

124.5

74.9

H04AA01

ATC

glucagon; nasal, parenteral

124.5

74.9

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

74.8

2683

17019

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

74.7

350

1052

J96.1

ICD-10 Finland

Chronic respiratory failure

6.6

74.6

127

172

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

237.7

74.6

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

683.1

74.6

P01

ICPC

Feeling anxious/nervous/tense

2.2

74.6

740

3183

XA800

NOMESCO Finland

Neuropsychological investigation

3.8

74.5

241

572

P74

ICPC

Anxiety disorder/anxiety state

3.9

74.4

231

532

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

74.3

170

307

U04

ICPC

Incontinence urine

3.3

74.3

300

825

L12

ICPC

Hand/finger symptom/complaint

1.9

74.3

1182

6010

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.6

74.2

470

1659

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

10.0

74.1

C01CA24

ATC

epinephrine; parenteral

2.5

74.0

512

1886

I44.2

ICD-10 Finland

Atrioventricular block, complete

7.5

73.7

111

131

K91

ICPC

Cerebrovascular disease

18.3

73.6

K50.9

ICD-10 Finland

Crohn disease, unspecified

674.1

73.6

A08

ICPC

Swelling

3.2

73.6

305

852

WX723

NOMESCO Finland

CPAP therapy

3.4

73.5

286

768

TGC00

NOMESCO Finland

Bronchial lavation

4.7

72.9

176

333

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

72.8

608

2436

M35.7

ICD-10 Finland

Hypermobility syndrome

11.9

72.7

SPAT1312

SPAT

General health counselling

1.7

72.7

1935

11387

N05BA02

ATC

chlordiazepoxide; systemic

7.6

72.6

109

128

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.1

72.6

103

113

T82

ICPC

Obesity

4.1

72.5

212

467

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

19.0

72.4

C08CA02

ATC

felodipine; oral

2.7

72.2

422

1430

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

72.2

264

681

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

335.6

72.1

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

72.0

502

1855

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

71.8

969

4662

WX140

NOMESCO Finland

Parabulbar anesthesy

4.3

71.6

195

407

ENC30

NOMESCO Finland

Plastic operation of pharynx

13.2

71.5

K99

ICPC

Cardiovascular disease other

6.9

71.4

117

152

M01AH02

ATC

rofecoxib; oral

2.1

71.4

739

3230

M01CB01

ATC

sodium aurothiomalate; parenteral

34.0

71.2

N06AA12

ATC

doxepin; systemic

3.7

71.1

236

570

SPAT1211

SPAT

Application of soft bandage

2.5

71.1

505

1882

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.3

70.8

126

179

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

70.7

461

1650

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

647.2

70.7

L08

ICPC

Shoulder symptom/complaint

1.7

70.3

1525

8486

A10AA01, ,

ATC

326.6

70.1

N18

ICPC

Paralysis/weakness

7.8

70.1

103

118

J01DA06

ATC

[U] cefuroxime

1.9

70.0

987

4818

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.0

69.8

206

457

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

69.8

485

1789

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

16.2

69.7

E86

ICD-10 Finland

Volume depletion

6.8

69.5

115

151

A10BG03

ATC

pioglitazone; oral

168.8

69.5

UJF92

NOMESCO Finland

Capsular endoscopy

6.6

69.4

117

157

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.7

69.0

170

327

E83.51

ICD-10 Finland

Hypocalcemia

10.0

68.9

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

629.2

68.7

U05

ICPC

Urination problems other

3.2

68.6

293

834

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

68.5

241

606

F60.9

ICD-10 Finland

Personality disorder, unspecified

18.7

68.5

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

9.7

68.4

R03BC03

ATC

nedocromil; inhalant

2.4

68.3

516

1977

I47.2

ICD-10 Finland

Ventricular tachycardia

135.0

68.3

N06AB05

ATC

paroxetine; oral

3.1

68.1

308

907

N03AF01

ATC

carbamazepine; oral, rectal

3.2

68.0

280

779

N06AG02

ATC

moclobemide; oral

3.8

67.8

221

527

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

7.3

67.8

105

128

L13

ICPC

Hip symptom/complaint

1.8

67.8

1214

6386

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.0

67.5

200

445

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.6

67.5

168

326

U07

ICPC

Urine symptom/complaint other

2.4

67.4

523

2028

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.4

67.4

180

370

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.7

67.4

163

309

IGY99

NOMESCO Finland

Other psychiatric treatment contact

8.9

67.3

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.6

67.3

413

1434

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

5.7

67.3

133

210

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

67.2

5181

38573

K59.1

ICD-10 Finland

Functional diarrhoea

3.0

67.0

317

958

C09CA06

ATC

candesartan; oral

1.7

67.0

1548

8751

P99

ICPC

Psychological disorders other

5.7

66.9

130

202

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

66.8

1271

6803

K59.0

ICD-10 Finland

Constipation

2.9

66.6

337

1057

AN3

Balloon angioplasty and metallic stent

+∞

66.5

P29

ICPC

Psychological sympt/compl other

2.7

66.4

384

1294

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

7.3

66.3

103

126

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.2

66.2

280

792

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

66.2

169

335

N06AX22

ATC

agomelatine; oral

6.3

65.9

116

163

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.3

65.8

257

692

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

65.7

750

3396

A01AB04

ATC

amphotericin B; local oral

3.1

65.6

296

870

R00.2

ICD-10 Finland

Palpitations

2.3

65.6

541

2154

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

65.5

L95

ICPC

Osteoporosis

3.6

65.5

228

569

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

65.4

1439

8020

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.6

65.4

165

324

A02BA04

ATC

nizatidine; systemic

2.6

65.2

409

1435

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.7

65.1

221

542

S22.3

ICD-10 Finland

Fracture of rib

2.5

65.1

442

1612

A07EA02

ATC

hydrocortisone; rectal

8.9

65.1

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.1

64.8

293

862

RD210, ,

NOMESCO Finland

6.7

64.8

108

143

H03BB01

ATC

carbimazole; oral

2.8

64.6

336

1070

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

7.1

64.5

103

130

E87.6

ICD-10 Finland

Hypokalaemia

4.3

64.4

177

372

K22.1

ICD-10 Finland

Ulcer of oesophagus

8.0

64.3

102

K02.1

ICD-10 Finland

Caries of dentine

1.5

64.2

4124

29385

R04

ICPC

Breathing problem other

3.3

64.2

253

685

K92.1

ICD-10 Finland

Melaena

3.3

64.1

254

690

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

64.0

316

978

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

63.5

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

63.5

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.5

63.5

128

206

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.4

63.5

238

624

U02

ICPC

Urinary frequency/urgency

1.9

63.3

923

4546

K29

ICPC

Cardiovascular sympt/complt other

3.7

63.2

213

520

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

12.1

63.2

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

63.0

311

962

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

27.7

63.0

XG405

NOMESCO Finland

Education on PEF monitoring

5.7

63.0

123

192

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.2

62.9

123

J01DA09

ATC

[U] cefadroxil

1.6

62.5

1753

10391

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

62.5

203

483

R49

ICD-10 Finland

Voice disturbances

12.1

62.4

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

62.4

1067

5523

K05.31

ICD-10 Finland

Periodontitis pronounced

2.1

62.3

641

2789

M05BX04

ATC

denosumab; parenteral

2.7

62.3

352

1171

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

25.0

62.2

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.7

62.2

153

294

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

8.5

62.1

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

20.0

62.1

SPAT1054

SPAT

Examination of peripheral nervous system

15.6

61.9

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

10.9

61.8

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

11.1

61.7

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

61.7

1486

8470

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

9.8

61.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

61.6

352

1178

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.2

61.6

172

366

XCK00

NOMESCO Finland

Perimetry

2.9

61.6

309

965

K50.8

ICD-10 Finland

Other Crohn disease

+∞

61.5

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

61.5

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

20.5

61.5

V03AA01, ,

ATC

9.9

61.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.1

61.4

275

805

QDB10, ,

SPAT

4.7

61.3

148

280

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

13.4

61.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

61.1

550

2270

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.5

61.0

220

562

CK2S4, ,

SPAT

19.2

61.0

TFP35

NOMESCO Finland

Electroanatomical mapping

15.1

61.0

SPAT1281

SPAT

Other administrative function

2.5

60.9

415

1515

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

557.5

60.8

Single vessel balloon catheter extension

+∞

60.5

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

6.2

60.5

108

154

D11

ICPC

Diarrhoea

2.0

60.5

751

3501

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

60.5

200

482

M01AC06

ATC

meloxicam; systemic, rectal

1.5

60.4

2336

14901

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

19.6

60.4

R12

ICD-10 Finland

Heartburn

2.2

60.4

559

2333

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.0

60.3

286

865

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

60.3

327

1065

M01AB05

ATC

diclofenac; systemic, rectal

1.5

60.1

4662

34309

N05AN01

ATC

lithium; oral

8.8

60.0

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

60.0

846

4118

ZXD20

NOMESCO Finland

Day surgery

1.9

60.0

854

4170

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

59.9

1492

8570

W19

ICD-10 Finland

Unspecified fall

2.2

59.9

559

2341

SPAT1059

SPAT

Spirometry at the office

3.0

59.8

278

831

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

59.7

1794

10796

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

59.6

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

59.4

427

1598

N18.8

ICD-10 Finland

Other chronic renal failure

7.2

59.3

115

R4180, ,

SPAT

16.5

59.3

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.1

59.1

172

378

N19

ICD-10 Finland

Unspecified kidney failure

4.5

58.9

149

293

L86

ICPC

Back syndrome with radiating pain

2.5

58.6

381

1360

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

58.6

318

1036

J96.0

ICD-10 Finland

Acute respiratory failure

10.0

58.5

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

5.6

58.5

117

187

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

9.2

58.5

SPAT1081

SPAT

Cardiorespiratory global assessment

3.1

58.5

259

753

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

8.6

58.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

186.2

58.0

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.5

57.9

147

290

EBA00

NOMESCO Finland

Extraction of tooth

1.5

57.9

2260

14419

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.6

57.9

145

283

WX780

NOMESCO Finland

Remote monitoring CPAP

3.1

57.9

261

767

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

7.2

57.8

113

E21.0

ICD-10 Finland

Primary hyperparathyroidism

4.5

57.8

146

287

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.4

57.7

WX199

NOMESCO Finland

Other local analgesia

4.1

57.6

165

358

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.4

57.6

118

193

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

57.4

282

870

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

11.3

57.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.6

56.8

194

478

C07AB03

ATC

atenolol; systemic

3.2

56.8

233

647

Z01.2

ICD-10 Finland

Dental examination

1.5

56.7

3324

23036

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

96.1

56.6

R74

ICPC

Upper respiratory infection acute

1.5

56.6

2346

15148

J01FA15

ATC

telithromycin; oral

2.0

56.5

679

3125

L04AA06

ATC

mycophenolic acid; systemic

6.6

56.5

130

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

9.9

56.4

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

4.0

56.3

168

376

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

56.3

337

1155

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.4

56.2

116

191

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

56.2

916

4664

H02AB09

ATC

hydrocortisone; systemic

4.1

56.1

160

346

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

7.5

56.1

101

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

56.0

236

666

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.7

55.9

123

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.0

55.8

254

750

N05AB01

ATC

dixyrazine; systemic

11.8

55.8

N06AB08

ATC

fluvoxamine; oral

4.7

55.8

135

256

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

55.6

194

485

ACC51

NOMESCO Finland

Release of median nerve

2.2

55.6

490

2003

R01AD01

ATC

beclometasone; nasal

1.8

55.4

1038

5506

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

55.3

314

1047

XJC10

NOMESCO Finland

Oesophageal pH monitoring

22.9

55.3

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

55.3

252

745

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

10.5

55.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.4

55.3

212

564

R03DC01

ATC

zafirlukast; oral

5.2

55.2

119

204

JN4BD

NOMESCO Finland

Extensive body CT

2.0

55.1

655

3003

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.0

55.0

254

757

WX882

NOMESCO Finland

High dependency care

4.2

54.7

153

326

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

16.4

54.7

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

54.6

375

1373

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

54.6

N06AX05

ATC

trazodone; oral

5.3

54.5

114

190

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

54.4

373

1365

R06AX22

ATC

ebastine; oral

1.7

54.4

1210

6730

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

12.6

54.4

XKC03

NOMESCO Finland

Water cystometry

3.7

54.4

180

434

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.9

54.2

268

830

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

31.3

54.2

R63.4

ICD-10 Finland

Abnormal weight loss

3.1

54.2

237

684

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

54.1

366

1331

TK800

NOMESCO Finland

Hemodialysis

6.6

54.0

122

S21

ICPC

Skin texture symptom/complaint

1.8

53.8

957

4997

WX320

NOMESCO Finland

Spinalanesthesy

1.6

53.8

1466

8587

E66

ICD-10 Finland

Obesity

2.8

53.7

295

967

Coronary artery bypass surgery

+∞

53.6

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

53.6

G04CB01

ATC

finasteride; oral

2.2

53.5

486

2011

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.5

53.4

136

269

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

253.9

53.4

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.8

53.4

168

391

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

53.3

666

3106

A97

ICPC

No disease

1.7

53.3

1259

7111

K08.3

ICD-10 Finland

Retained dental root

2.3

53.3

426

1671

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.0

53.2

242

715

G04BD08

ATC

solifenacin; oral

2.5

52.8

346

1239

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

52.7

1048

5648

R06.4

ICD-10 Finland

Hyperventilation

5.4

52.6

109

180

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

3.0

52.6

253

771

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

52.6

FL1AC

NOMESCO Finland

Left cardioangiography

+∞

52.6

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

52.6

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

52.5

263

820

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.8

52.5

927

4828

M01AX05

ATC

glucosamine; oral

1.7

52.5

1005

5359

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

13.4

52.3

J01EA01

ATC

trimethoprim; systemic

1.6

52.3

1554

9286

F32

ICD-10 Finland

Depressive episode

2.9

52.2

263

823

B01AB04

ATC

dalteparin; parenteral

2.7

52.2

308

1048

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.6

52.1

181

451

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

12.1

52.1

GD2SN

NOMESCO Finland

Lung ventilation SPECT

17.7

52.1

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

62.2

52.0

K50.0

ICD-10 Finland

Crohn disease of small intestine

128.5

52.0

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.5

51.9

333

1180

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

51.8

1897

11881

TKC22

NOMESCO Finland

Catheterisation instruction

5.5

51.8

105

170

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

51.7

323

1130

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.3

51.5

202

545

I71.01

ICD-10 Finland

Aneurysm of the descending aorta

26.5

51.5

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

18.1

51.5

SPAT1252

SPAT

Overall medication plan or its review

2.8

51.5

266

844

WZC00, ,

SPAT

1.8

51.4

876

4514

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

51.3

467

1934

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.9

51.1

159

367

M01AB55

ATC

diclofenac, combinations; oral

2.5

51.1

344

1248

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.0

51.1

245

746

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

126.3

51.0

K29.7

ICD-10 Finland

Gastritis, unspecified

3.3

51.0

203

553

WX730

NOMESCO Finland

Conventional respirator

6.3

50.9

127

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.8

50.9

163

384

A10BH02

ATC

vildagliptin; oral

468.0

50.9

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

3.2

50.8

207

572

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

50.8

314

1093

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.1

50.8

146

318

NHQ40

NOMESCO Finland

Amputation of toe

10.9

50.7

H25.9

ICD-10 Finland

Senile cataract, unspecified

11.2

50.7

A10BX01

ATC

guar gum; oral

4.9

50.5

115

207

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

6.8

50.2

109

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.0

50.2

151

340

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

7.2

50.0

C09CA03

ATC

valsartan; oral

2.2

50.0

453

1872

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.4

49.9

121

J43.9

ICD-10 Finland

Emphysema, unspecified

6.1

49.8

133

F22.0

ICD-10 Finland

Delusional disorder

25.8

49.8

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

49.7

4704

35304

A06AC51

ATC

ispaghula, combinations; oral

2.7

49.7

290

981

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.8

49.7

117

217

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

49.6

493

2112

A11CC02

ATC

dihydrotachysterol; oral

19.5

49.6

C09BA02

ATC

enalapril and diuretics; systemic

2.5

49.6

324

1159

L15

ICPC

Knee symptom/complaint

1.6

49.5

1589

9649

Z51.5

ICD-10 Finland

Palliative care

2.1

49.4

508

2205

GD1LA

NOMESCO Finland

10.5

49.4

K85

ICPC

Elevated blood pressure

1.8

49.3

927

4911

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.8

49.2

G72.8

ICD-10 Finland

Other specified myopathies

8.1

49.2

R01AD05

ATC

budesonide; nasal

2.1

49.2

522

2293

A02BX02

ATC

sucralfate; oral

3.1

49.2

218

634

B03BA03

ATC

hydroxocobalamin; parenteral

2.9

49.2

250

786

SFA10

NOMESCO Finland

One-surface restoration

1.4

49.1

3760

27128

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

49.0

116

216

J01MA01

ATC

ofloxacin; systemic

2.1

48.9

491

2113

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

48.8

223

660

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.6

48.8

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.1

48.8

210

600

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

48.8

762

3820

K04

ICPC

Palpitations/awareness of heart

2.6

48.7

308

1084

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.7

48.6

275

915

R06AE09

ATC

levocetirizine; oral

1.7

48.6

1017

5550

A10BX07

ATC

[U] liraglutide

+∞

48.6

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

48.6

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

+∞

48.6

K51.8

ICD-10 Finland

Other ulcerative colitis

230.8

48.5

GBB13

NOMESCO Finland

Revision of tracheostomy

24.0

48.5

I95.9

ICD-10 Finland

Hypotension, unspecified

6.8

48.4

105

G04CA01

ATC

alfuzosin; oral

1.9

48.4

630

2977

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

64.3

48.2

J47

ICD-10 Finland

Bronchiectasis

4.9

48.2

111

202

TJD20

NOMESCO Finland

Change of gastrostomy tube

10.1

48.1

C07AG02

ATC

carvedilol; oral

3.0

48.1

217

638

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.2

48.0

135

289

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

25.2

48.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.7

48.0

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

441.2

48.0

M10.0

ICD-10 Finland

Idiopathic gout

3.9

47.9

148

340

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

47.9

704

3462

F60.5

ICD-10 Finland

Anankastic personality disorder

9.5

47.7

L04

ICPC

Chest symptom/complaint

2.3

47.7

400

1600

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.8

47.7

142

M01AH05

ATC

etoricoxib; oral

1.4

47.6

4447

33166

SPAT1139

SPAT

Nutrition survey

3.9

47.5

147

338

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.9

47.5

S01BC05

ATC

ketorolac; ophthalmic

4.3

47.5

129

269

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

47.3

401

1611

A10AD05

ATC

insulin aspart; parenteral

153.5

47.3

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

47.3

728

3632

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

47.2

4749

35864

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

10.3

47.2

-50

ICPC

Medication/prescr/renewal

3.1

47.2

203

580

E10

ICD-10 Finland

Type 1 diabetes mellitus

117.4

47.2

M54

ICD-10 Finland

Dorsalgia

1.8

47.2

815

4211

E03

ICD-10 Finland

Other hypothyroidism

2.2

47.1

429

1775

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

12.8

47.0

H53.2

ICD-10 Finland

Diplopia

3.4

47.0

181

483

AA5PD

NOMESCO Finland

CT examination of brain pefusion

15.6

46.9

X57

ICD-10 Finland

Unspecified privation

3.8

46.8

151

358

C10AC01

ATC

colestyramine; oral

3.8

46.8

151

358

AA1

Conventional CABG

+∞

46.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.9

46.6

232

721

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

46.5

202

581

K22.7

ICD-10 Finland

Barrett oesophagus

7.3

46.4

I71.09

ICD-10 Finland

Aortic dissection [regardless of location]

13.4

46.4

R4130, ,

SPAT

13.4

46.4

P15

ICPC

Chronic alcohol abuse

4.9

46.4

107

195

F41.00

ICD-10 Finland

Moderate panic disorder

12.9

46.3

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

10.9

46.3

SAA04

NOMESCO Finland

Special examination of mouth

2.4

46.2

339

1279

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

4.5

46.2

116

227

L02

ICPC

Back symptom/complaint

1.9

46.2

658

3202

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.1

46.2

134

294

WW200

NOMESCO Finland

Immunization

3.4

46.1

172

450

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

46.0

277

952

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

45.9

1717

10759

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

17.3

45.9

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

10.1

45.8

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.3

45.7

180

487

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

8.2

45.7

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.1

45.7

204

596

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

45.7

151

364

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

45.7

405

1658

H36.00

ICD-10 Finland

Diabetic background retinopathy

+∞

45.6

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

45.6

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

13.0

45.6

E000001, ,

ATC

1.6

45.4

1217

7068

KED33

NOMESCO Finland

Transurethral incision of prostate

7.0

45.4

D12

ICPC

Constipation

3.1

45.3

203

594

XJH00

NOMESCO Finland

Transanal ultrasonography

2.6

45.2

283

991

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.4

45.2

167

434

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

45.1

318

1179

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

45.0

199

578

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

45.0

1394

8376

H01

ICPC

Ear pain/earache

1.8

44.9

770

3967

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

44.8

385

1556

R28

ICPC

Limited function/disability (R)

5.4

44.8

151

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.1

44.7

174

G04BD07

ATC

tolterodine; oral

2.8

44.7

231

733

K22.2

ICD-10 Finland

Oesophageal obstruction

6.9

44.7

162

Kela drug reimbursment

liraglutide

+∞

44.6

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

44.3

127

276

K74

ICPC

Ischaemic heart dis with angina

76.8

44.3

JF1AD

NOMESCO Finland

Small bowel CT

10.5

44.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.3

44.2

156

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.0

44.2

133

300

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.4

44.0

147

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

15.8

44.0

H26.9

ICD-10 Finland

Cataract, unspecified

7.7

44.0

Z01.7

ICD-10 Finland

Laboratory examination

1.6

43.9

1061

6002

WX704

NOMESCO Finland

Intubation

2.0

43.8

519

2371

M02AA10

ATC

ketoprofen; topical

1.7

43.8

935

5121

WX290

NOMESCO Finland

Other blockage of nerve

1.4

43.8

3200

22731

R32

ICD-10 Finland

Unspecified urinary incontinence

3.7

43.8

143

342

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

43.7

519

2374

F32.8

ICD-10 Finland

Other depressive episodes

7.0

43.6

L29

ICPC

Musculoskeletal sympt/complt other

2.0

43.6

526

2419

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

43.6

1646

10320

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

5.6

43.5

136

H02.3

ICD-10 Finland

Blepharochalasis

2.2

43.4

395

1633

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

9.4

43.4

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

22.1

43.3

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

43.3

1377

8316

M05BA07

ATC

risedronic acid; oral

4.0

43.2

129

289

L16

ICPC

Ankle symptom/complaint

1.8

43.2

714

3636

K07.60

ICD-10 Finland

Snapping jaw

2.3

43.2

365

1464

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

43.2

385

1579

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.7

43.1

242

802

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

5.8

43.1

128

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

43.1

652

3232

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

396.5

43.0

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

8.4

43.0

GD1UN

NOMESCO Finland

Lung circulation SPECT

17.7

43.0

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.0

42.9

128

287

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

42.8

239

790

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

42.7

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

42.7

DHB50

NOMESCO Finland

Turbinoplasty

3.2

42.5

175

487

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

42.4

636

3143

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

73.8

42.4

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

73.8

42.4

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

86.8

42.4

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

3.3

42.1

164

441

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.0

42.1

126

283

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.6

42.1

104

201

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

13.8

42.0

SFA20

NOMESCO Finland

Two-surface restoration

1.4

42.0

4057

30129

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

42.0

179

509

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

6.6

41.9

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

41.8

225

730

D06

ICPC

Abdominal pain localized other

1.9

41.8

563

2688

IBA03

NOMESCO Finland

Psychotherapy evaluation

18.7

41.7

R49.02

ICD-10 Finland

Spasmodic dysphonia

15.7

41.7

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

41.7

270

961

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

41.7

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

41.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.3

41.6

112

232

C05AA08

ATC

fluocortolone; rectal, topical

1.7

41.6

816

4365

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

9.0

41.4

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

41.4

269

959

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

6.9

41.4

S01ED51

ATC

timolol, combinations; ophthalmic

2.4

41.3

301

1132

XA402

NOMESCO Finland

ENMG

3.2

41.3

171

478

UGC02

NOMESCO Finland

Rigid bronchoscopy

10.6

41.2

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

13.3

41.2

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

12.7

41.1

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

41.1

314

1206

3051, ,

Kela drug reimbursment

12.2

41.1

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

12.2

41.1

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

378.6

41.1

R06AX13

ATC

loratadine; oral

1.6

41.0

986

5563

M01AB01

ATC

indometacin; systemic, rectal

2.3

41.0

345

1381

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.5

41.0

269

964

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

41.0

246

844

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

9.6

40.9

SPAT1167

SPAT

Insertion of urinary catheter

4.3

40.8

111

232

ZXC60

NOMESCO Finland

Application of heat

4.9

40.7

168

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

194.6

40.7

A10BG02

ATC

rosiglitazone; oral

+∞

40.7

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

10.1

40.7

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

40.6

433

1903

S04

ICPC

Lump/swelling localized

1.8

40.6

701

3614

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

6.2

40.6

105

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

5.9

40.6

114

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

5.4

40.5

136

A10AD01

ATC

insulin (human); parenteral

83.2

40.4

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.0

40.4

447

1992

F33

ICD-10 Finland

Recurrent depressive disorder

4.1

40.4

114

245

J01MA06

ATC

norfloxacin; oral

1.7

40.4

772

4098

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

12.3

40.4

E87.5

ICD-10 Finland

Hyperkalaemia

7.3

40.3

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.4

40.3

148

383

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.9

40.2

123

281

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

40.1

202

632

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.9

40.1

545

2608

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

369.7

40.1

WF002

NOMESCO Finland

Radical radiotherapy

2.1

40.0

399

1711

R51

ICD-10 Finland

Headache

2.2

39.9

375

1570

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

39.9

191

581

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.1

39.9

104

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

3.6

39.8

138

344

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.6

39.8

137

340

AP1

Catheterization of the left side of the heart

190.2

39.8

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

10.7

39.7

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

39.7

638

3219

AS4

Physiological pacemaker insertion DDD (R)

12.9

39.7

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

39.7

C09DX04

ATC

valsartan and sacubitril; oral

+∞

39.7

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.9

39.6

120

272

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

6.1

39.5

105

C10AA02

ATC

lovastatin; oral

3.5

39.5

144

371

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.6

39.5

231

782

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

99.6

39.5

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

39.5

406

1761

J01DC02

ATC

cefuroxime; systemic

2.2

39.4

361

1496

C09DA01

ATC

losartan and diuretics; oral

1.9

39.4

513

2419

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

39.3

294

1119

R01AD11

ATC

triamcinolone; nasal

1.9

39.3

549

2651

S80.0

ICD-10 Finland

Contusion of knee

1.9

39.2

497

2323

J05AB01

ATC

aciclovir; systemic

1.5

39.2

1397

8627

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.9

39.2

121

278

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

39.2

615

3080

D07XC01

ATC

betamethasone; topical

1.8

39.2

698

3631

N01

ICPC

Headache

1.8

39.2

673

3464

M54.3

ICD-10 Finland

Sciatica

2.2

39.2

353

1454

Z00.8

ICD-10 Finland

Other general examinations

2.0

39.1

478

2206

F29

ICPC

Eye symptom/complaint other

1.8

39.1

672

3458

AQ1

Conventional electrophysiological examination

17.2

39.1

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.9

39.1

187

569

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

10.4

39.1

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.9

39.0

503

2365

H13

ICPC

Plugged feeling ear

1.6

39.0

1075

6267

N19

ICPC

Speech disorder

5.5

39.0

128

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.8

38.9

199

628

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.6

38.9

240

835

OAB42, ,

SPAT

1.8

38.9

666

3425

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

38.8

120

276

K92.0

ICD-10 Finland

Haematemesis

4.2

38.8

107

226

SPAT1304

SPAT

Counselling and guidance related to ageing

2.4

38.8

273

1011

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

7.1

38.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

38.7

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

38.7

M54.1

ICD-10 Finland

Radiculopathy

2.6

38.6

243

853

N06AA06

ATC

trimipramine; systemic

4.0

38.5

115

258

SPAT1360

SPAT

Extensive global examination

2.2

38.5

348

1435

KH1AD

NOMESCO Finland

CT of urinary organs

2.7

38.4

215

712

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

38.3

148

396

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

38.3

500

2360

K28

ICPC

Limited function/disability (K)

5.5

38.3

124

C07AB08

ATC

celiprolol; oral

4.4

38.2

199

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

38.1

169

492

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

38.0

475

2210

S20

ICPC

Corn/callosity

5.0

38.0

151

N05AL01

ATC

sulpiride; systemic

7.1

38.0

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

37.9

114

257

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

37.9

225

768

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

37.9

753

4038

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.9

37.8

Catheterization and pressure measurement of the left side of the heart

58.1

37.8

SFA30

NOMESCO Finland

Three-surface restoration

1.4

37.8

2768

19524

S10

ICPC

Boil/carbuncle

2.3

37.7

312

1240

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

37.7

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

37.7

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

77.9

37.6

K08.80

ICD-10 Finland

Toothache NOS

1.8

37.6

622

3165

RS221, ,

NOMESCO Finland

5.5

37.6

123

K01

ICPC

Heart pain

7.0

37.5

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

9.2

37.5

4CJ01, ,

NOMESCO Finland

9.2

37.5

C08CA07

ATC

nisoldipine; oral

16.7

37.4

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.0

37.4

177

535

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

37.4

315

1262

D07AD01

ATC

clobetasol; topical

1.6

37.4

1054

6173

S76

ICPC

Skin infection other

2.4

37.3

277

1051

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

8.7

37.3

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

8.7

37.3

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.7

37.3

210

698

IGY02, ,

SPAT

6.6

37.2

A03

ICPC

Fever

1.6

37.2

1072

6309

R4120, ,

SPAT

5.5

37.2

121

R03BB07

ATC

umeclidinium bromide; inhalant

6.4

37.2

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.7

37.1

168

I20.9

ICD-10 Finland

Angina pectoris, unspecified

10.2

36.9

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

36.8

137

358

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.7

36.8

121

291

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

36.7

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

7.5

36.5

-1, ,

NOMESCO Finland

1.4

36.4

2072

13976

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.6

36.4

127

318

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.8

36.3

190

607

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.1

36.3

105

230

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

36.3

2793

19822

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

3.2

36.3

152

428

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

36.3

655

3418

L04AB04

ATC

adalimumab; parenteral

4.6

36.2

168

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.0

36.2

392

1733

J05.1

ICD-10 Finland

Acute epiglottitis

10.3

36.2

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.6

36.1

112

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.5

36.0

126

316

K83

ICPC

Heart valve disease NOS

13.1

36.0

N02AC04

ATC

dextropropoxyphene; oral

2.9

35.8

172

525

DQB70

NOMESCO Finland

Total excision of vocal cord

117.9

35.7

H26.2

ICD-10 Finland

Complicated cataract

117.9

35.7

H3600, E113,

ICD-10 Finland

+∞

35.7

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

35.7

280

Kela drug reimbursment

Clopidogrel

+∞

35.7

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

35.7

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

90.7

35.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

35.7

153

437

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

9.7

35.6

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.9

35.6

172

526

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

35.6

229

813

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.6

35.5

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

6.4

35.4

R07.2

ICD-10 Finland

Precordial pain

4.3

35.4

193

L05

ICPC

Flank/axilla symptom/complaint

2.1

35.3

370

1615

M15

ICD-10 Finland

Polyarthrosis

2.3

35.3

273

1055

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

3.9

35.2

109

251

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.8

35.2

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.3

35.2

282

1106

H53.4

ICD-10 Finland

Visual field defects

4.2

35.2

205

I48.3

ICD-10 Finland

Typical atrial flutter

325.1

35.2

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

325.1

35.2

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.3

35.1

272

1051

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.6

35.1

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.5

35.1

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.6

35.0

121

301

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

34.9

255

961

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

34.8

252

945

KED22

NOMESCO Finland

Transurethral resection of prostate

2.6

34.8

202

682

B82

ICPC

Anaemia other/unspecified

3.5

34.7

126

324

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

34.7

A04AA01

ATC

ondansetron; systemic, rectal

1.8

34.5

590

3029

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

7.6

34.5

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

9.3

34.4

D07AC13

ATC

mometasone; topical

1.4

34.4

1785

11823

N29

ICPC

Neurological sympt/complt other

3.8

34.3

110

260

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.1

34.3

147

420

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

6.0

34.2

F31

ICD-10 Finland

Bipolar affective disorder

7.8

34.2

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

316.1

34.2

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022948) Iron [Moles/volume] in Serum or Plasma

1580

5029

3.22

323.31

2.7

1.8

13.17

15.45

umol/l

22.72

1457

4707

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1377

4026

3.45

323.31

2.7

1.8

22.58

26.40

15.18

1257

3741

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1476

4510

3.32

323.01

2.7

1.8

2.36

2.35

g/l

0.46

1347

4173

(3031040) Bacteria [#/volume] in Urine by Automated count

5280

30876

2.61

319.56

5.5

3.2

1270.93

1417.67

e6/l

0.06

400

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

794

1591

4.78

312.05

4.5

2.9

5.21

5.12

kpa

1.93

759

1526

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1181

3217

3.63

307.85

2.2

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1150

2891

3.94

307.65

2.6

2.8

364.43

393.50

nmol/l

3.98

1063

2741

(3018418) pH of Serum or Plasma

2773

10980

2.91

307.65

5.6

3.5

7.40

0.28

2037

7469

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3614

16122

2.83

307.65

2.3

1.6

97.24

99.55

pmol/l

1.94

1991

7946

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

756

1368

5.28

307.65

2.5

1.4

7.78

3.54

ug/l

4.91

649

1178

(3001604) Monocytes [#/volume] in Blood

4633

21988

3.14

307.65

6.9

4.3

0.58

0.54

e9/l

20.98

4098

18702

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1738

4813

3.81

307.65

2.3

1.6

—

(3003396) Base excess in Arterial blood by calculation

1176

2973

3.93

307.65

10.6

5.5

1.26

0.77

mmol/l

4.38

1001

2470

(3006504) Eosinophils/Leukocytes in Blood

4289

20322

2.93

307.65

7.1

4.4

2.81

2.92

1.99

4041

19002

(3012516) Albumin [Mass/volume] in Urine

2430

7931

3.48

307.65

3.5

1.9

46.17

44.19

mg/l

0.11

1502

3768

(3009508) Creatinine [Moles/volume] in Urine

2629

9084

3.35

307.65

3.4

1.9

7.46

8.37

mmol/l

16.88

2190

7767

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4591

22133

3.04

307.65

7.7

6.8

10.83

11.33

umol/l

1.65

4362

21139

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1902

5297

3.87

307.65

4.2

3.6

0.81

0.83

mmol/l

8.52

1801

4987

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2832

9685

3.49

307.65

2.5

1.6

197.00

181.27

u/l

0.40

2688

9121

(3019977) pH of Arterial blood

1192

2981

3.98

307.65

10.6

5.5

7.42

0.03

650

1475

(40768797) Stomach Pathology biopsy report

1639

4581

3.73

307.65

1.4

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1420

3596

4.03

307.65

6.3

4.6

1.04

1.02

mmol/l

1.63

1318

3285

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2432

8072

3.41

307.65

2.5

1.7

2.75

2.53

mg/l

5.15

2087

6822

(3024561) Albumin [Mass/volume] in Serum or Plasma

3999

17027

3.22

307.65

5.6

4.2

35.72

36.67

g/l

20.32

3731

15971

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1471

4392

3.41

307.65

2.4

1.9

29.78

28.73

7.21

1432

4278

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4616

19068

3.82

307.65

9.8

5.0

1.21

1.22

mmol/l

26.05

4016

16352

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1289

3375

3.83

307.65

2.1

1.5

—

(3016502) Oxygen saturation in Arterial blood

1059

2526

4.12

307.65

11.2

5.9

95.92

96.72

4.51

1019

2431

(3027801) Oxygen [Partial pressure] in Arterial blood

1190

2980

3.97

307.65

10.6

5.5

12.20

14.50

kpa

34.22

1133

2867

(3013115) Eosinophils [#/volume] in Blood

4764

23002

3.16

307.65

7.1

4.4

0.19

e9/l

1.01

4259

19882

(3018010) Neutrophils/Leukocytes in Blood

4287

20822

2.83

307.65

6.9

4.3

57.79

55.62

27.43

4112

19872

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2681

6802

4.79

307.65

3.6

1.7

1044.09

318.64

ng/l

22.86

2284

5473

(3021960) Folate [Moles/volume] in Serum or Plasma

2407

9463

2.80

307.65

1.8

1.4

19.82

20.70

nmol/l

1.82

2045

7942

(3015377) Calcium [Moles/volume] in Serum or Plasma

3236

15019

2.55

307.65

3.9

4.1

2.34

2.36

mmol/l

7.33

2927

13812

(3013650) Neutrophils [#/volume] in Blood by Automated count

5019

25921

3.02

307.65

10.5

8.0

4.16

3.78

e9/l

24.84

4460

22154

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5967

35785

3.08

307.65

5.6

2.7

11.72

9.42

mm/h

32.16

5605

33527

(3013826) Glucose [Moles/volume] in Serum or Plasma

4933

22931

3.49

307.65

6.9

3.2

6.51

6.04

mmol/l

51.66

4732

21286

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6087

35685

3.39

307.65

10.4

6.4

77.11

77.96

u/l

0.62

5815

33734

(3032080) INR in Blood by Coagulation assay

4042

15115

3.85

307.65

15.9

4.3

1.21

1.07

inr

60.87

3395

11928

(3019198) Lymphocytes [#/volume] in Blood

4695

22711

3.10

307.65

7.0

4.3

1.87

1.95

e9/l

2.93

4236

19841

(3019309) Folate [Moles/volume] in Red Blood Cells

1501

4119

3.74

307.65

1.8

1.5

1149.15

1127.77

nmol/l

0.37

1111

3124

(3019069) Monocytes/Leukocytes in Blood

4305

20377

2.95

307.65

7.1

4.4

8.78

8.66

1.68

4055

19084

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1742

5819

3.11

307.65

4.7

2.1

393.18

72.36

ng/l

3.45

1307

3639

(3023368) Bacteria identified in Blood by Culture

2557

8944

3.27

307.65

5.0

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3363

12710

3.36

307.65

4.4

1.8

34.30

18.90

ng/l

2.45

2295

6422

(3006315) Basophils [#/volume] in Blood

4631

22027

3.13

307.65

6.9

4.3

0.04

e9/l

3.45

4095

18728

(3020682) Albumin/Creatinine [Ratio] in Urine

2461

8028

3.49

307.65

4.1

2.0

7.99

6.27

mg/mmol

0.94

1481

3776

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2919

12514

2.69

307.65

3.1

2.3

69.94

68.40

u/l

0.05

2670

11667

(3022096) Basophils/Leukocytes in Blood

4279

20318

2.92

307.65

7.2

4.4

0.69

0.70

0.80

4021

18971

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4258

16695

3.78

307.65

9.1

4.6

1.21

1.22

mmol/l

18.00

3972

15378

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1191

2981

3.98

307.65

10.6

5.5

5.22

5.14

kpa

1.56

1134

2869

(3002030) Lymphocytes/Leukocytes in Blood

4362

21243

2.86

307.65

7.0

4.4

27.35

29.69

37.43

4160

20149

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3899

20115

2.43

304.92

2.8

1.9

78.76

78.35

nmol/l

0.39

3571

18520

(3009343) pH of Capillary blood

767

1552

4.72

297.52

4.5

2.9

7.41

7.42

2.84

637

1252

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

942

2243

4.07

296.76

4.1

2.9

75.13

68.95

ng/l

1.55

821

1998

(3037467) Urinalysis macro (dipstick) panel - Urine

5358

32231

2.52

292.32

5.4

3.2

2.01

2.52

—

(3020779) Urea [Moles/volume] in Serum or Plasma

920

2186

4.07

290.41

7.3

5.1

8.85

7.53

mmol/l

6.04

875

2100

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1046

2753

3.71

285.76

4.9

3.8

4.54

4.61

pmol/l

1.03

962

2516

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6129

39579

2.78

283.38

6.5

3.8

15.11

14.44

pmol/l

71.63

5706

36741

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2236

9184

2.61

281.48

2.0

1.5

1.04

1.07

mg/l

0.19

1724

7058

(3013512) EKG study

2851

13167

2.44

279.12

4.3

2.2

0.88

0.78

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

969

2478

3.79

275.53

11.8

6.0

121.85

122.19

g/l

0.19

937

2407

(3014111) Lactate [Moles/volume] in Serum or Plasma

949

2409

3.81

272.59

10.6

5.6

1.31

1.20

mmol/l

2.07

930

2359

(3021447) Carbon dioxide [Partial pressure] in Venous blood

919

2328

3.81

264.43

4.3

3.2

5.92

5.81

kpa

2.13

897

2276

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

676

1358

4.70

263.70

4.2

3.0

1.68

1.52

mmol/l

0.49

515

1006

(3012544) pH of Venous blood

922

2360

3.77

261.25

4.4

3.2

7.38

0.07

489

1331

(3044640) Blood type and Crossmatch panel - Blood

3040

14801

2.33

259.88

2.9

2.0

—

(3026008) Bacteria identified in Urine by Culture

2510

11266

2.42

257.80

3.5

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

159

62.08

257.11

3.1

2.7

0.81

0.93

nmol/l

—

125

(3002032) Base excess in Venous blood by calculation

899

2287

3.78

256.82

4.4

3.2

2.12

1.98

mmol/l

0.48

799

2006

(3000991) Gas panel - Venous blood

893

2323

3.69

246.61

11.8

6.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4054

22694

2.21

241.99

3.2

2.4

—

estimate

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

318

322

9.02

239.04

9.2

8.3

24.43

125.81

ug/l

0.79

220

210

(3000850) Epithelial cells [#/volume] in Urine

2000

8333

2.50

238.78

3.0

2.1

4.86

5.81

e6/l

2.68

1812

7503

(3005719) IgG [Mass/volume] in Serum or Plasma

907

2436

3.58

238.58

3.1

2.6

10.18

10.60

g/l

1.58

829

2258

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

749

1779

4.00

234.88

1.7

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

2746

13244

2.28

234.71

3.9

2.5

55.83

67.62

e6/l

0.17

2135

9490

(3019060) Gas panel - Arterial blood

624

1305

4.49

231.00

6.0

3.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

668

1488

4.23

228.07

3.4

1.6

157.25

72.81

ng/l

8.42

616

1325

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2374

10906

2.32

226.00

2.9

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1255

4240

2.92

225.34

2.0

1.4

—

(3027945) Reticulocytes/Erythrocytes in Blood

1028

3096

3.22

225.19

2.7

1.78

1.58

7.22

904

2801

(3018095) Leukocytes [#/volume] in Urine

3106

16011

2.18

222.77

4.6

2.9

49.98

76.80

e6/l

3.44

2244

10397

(3015235) Bicarbonate [Moles/volume] in Capillary blood

430

667

5.95

222.57

3.0

2.3

25.05

24.87

mmol/l

0.37

421

654

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4045

23132

2.13

221.62

3.7

2.5

119.08

109.09

ug/l

1.27

3784

22033

(3042936) Bacteria identified in Isolate by Culture

1423

5199

2.73

220.22

2.2

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

2411

11302

2.28

217.35

3.8

2.4

0.31

0.36

e6/l

0.58

1804

7623

(3037522) Nuclear Ab [Titer] in Serum

1460

5444

2.68

216.80

1.4

1.3

559.23

395.83

titre

2.15

312

939

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6778

48352

2.95

213.11

7.8

4.2

1.78

1.86

mu/l

3.29

6366

45006

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1655

6617

2.53

212.74

1.7

1.4

4303105.16

36030501.33

pmol/l

4.01

1348

5723

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2786

13995

2.18

210.52

3.7

3.0

31.47

31.72

u/l

0.08

2626

13403

(3007164) IgA [Mass/volume] in Serum or Plasma

2031

8957

2.35

210.11

1.6

1.4

2.28

2.18

g/l

1.68

1290

5837

(3024354) Oxygen [Partial pressure] in Venous blood

747

1914

3.69

209.72

3.7

2.9

4.81

4.56

kpa

1.76

726

1870

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

354

487

6.65

205.68

9.2

6.1

64.07

122.88

u/ml

1.04

152

186

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7132

52629

3.62

204.99

22.8

8.5

22.53

24.87

mg/l

7.55

6236

38939

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

506

986

4.76

203.69

2.8

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

4179

24774

2.06

200.33

4.3

2.7

1.51

2.62

estimate

0.28

879

4464

(3033658) Prothrombin time (PT) actual/Normal

2312

10960

2.22

199.91

4.9

3.1

90.87

95.82

18.22

2267

10731

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

651

1566

3.90

199.71

1.9

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

4143

24518

2.05

199.09

4.3

2.7

0.00

estimate

0.30

877

4383

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

652

1576

3.88

198.64

13.2

6.7

24.72

24.39

mmol/l

1.83

638

1555

(36304419) Bacteria [Presence] in Urine

2300

10925

2.22

197.48

3.7

2.4

0.00

0.25

estimate

—

(3005322) IgE [Units/volume] in Serum or Plasma

984

3115

3.04

196.76

1.5

1.2

126.31

196.58

u/ml

4.41

934

2928

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1016

3279

2.99

196.38

2.4

2.2

0.21

0.22

g/l

3.43

966

3127

(3009261) Glucose [Presence] in Urine by Test strip

4207

25125

2.04

195.93

4.3

2.7

0.01

estimate

0.02

853

4448

(3023520) Reticulocytes [#/volume] in Blood

788

2202

3.39

193.50

2.6

2.9

69.31

65.70

e9/l

1.79

587

1556

(3009445) Proteinase 3 Ab [Units/volume] in Serum

519

1078

4.47

193.11

1.7

1.1

22.77

1.54

iu/ml

0.98

(3020630) Protein [Mass/volume] in Serum or Plasma

819

2352

3.31

192.54

2.5

3.2

66.02

67.17

g/l

3.73

751

2210

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1834

8005

2.33

191.99

3.2

3.3

2.45

2.44

mmol/l

1.70

1630

7266

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2231

10570

2.21

191.84

1.4

1.2

1.73

1.82

u/ml

0.10

584

3116

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

946

2969

3.06

191.78

1.6

1.4

—

(3019225) pH of Specimen

1043

3464

2.91

191.24

5.0

3.1

7.37

7.36

1.82

790

2300

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1108

3839

2.80

187.65

3.9

5.6

235.47

247.30

u/l

1.46

1051

3688

(3048689) Calprotectin [Mass/mass] in Stool

1332

5073

2.58

187.23

2.4

1.2

124.79

83.79

ug/g

4.06

1075

3888

(3028026) IgM [Mass/volume] in Serum or Plasma

696

1835

3.57

186.66

2.1

2.0

1.21

1.42

g/l

1.57

641

1693

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

370

592

5.73

185.18

3.1

2.4

0.33

0.35

iu/ml

0.64

196

274

(3008152) Bicarbonate [Moles/volume] in Arterial blood

598

1432

3.90

184.26

9.0

4.9

25.11

24.82

mmol/l

1.05

562

1354

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

590

1405

3.92

183.18

4.8

3.8

24.54

24.47

mmol/l

0.19

583

1395

(3026782) Osmolality of Urine

1656

7083

2.35

180.30

3.0

2.2

517.73

559.51

mosm/kgh2o

11.86

1437

6166

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

414

754

5.05

179.98

2.3

1.8

633.89

491.14

ug/l

0.15

394

706

(3015736) pH of Urine

3385

19144

1.99

178.08

3.7

2.5

6.22

6.19

0.91

1838

11098

(3021589) Normoblasts [#/volume] in Blood

3588

20926

1.95

170.22

13.3

7.3

0.00

e9/l

1.31

2971

16725

(3019550) Sodium [Moles/volume] in Serum or Plasma

7109

53554

3.20

169.39

25.3

9.1

139.59

139.94

mmol/l

28.62

7009

52121

(3023103) Potassium [Moles/volume] in Serum or Plasma

7114

53773

3.17

164.80

25.5

9.2

3.95

3.94

mmol/l

3.45

7004

52183

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

446

938

4.38

162.94

1.3

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

601

1570

3.57

162.85

12.7

6.4

16.19

16.46

1.39

575

1502

(3044889) 12 lead EKG panel

5083

33680

1.96

160.98

4.8

2.4

10102.20

0.46

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

480

1086

4.08

159.39

3.6

2.7

0.60

0.64

1.97

480

1081

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

480

1086

4.08

159.39

3.5

2.7

1.45

1.12

7.49

480

1076

(3004119) Hemoglobin [Mass/volume] in Venous blood

541

1341

3.74

158.24

3.7

2.7

128.70

132.15

g/l

2.46

516

1306

(3017732) Neutrophils [#/volume] in Blood

1242

4936

2.45

157.41

3.2

2.5

4.84

4.15

e9/l

1.05

1047

4410

(3023419) Bacteria identified in Sputum by Culture

251

318

7.14

156.87

3.2

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2179

10918

2.05

156.61

2.8

2.2

331.63

317.11

umol/l

8.60

1909

9938

(3000494) Fungus identified in Specimen by Culture

1318

5444

2.36

152.97

1.6

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

396

803

4.52

151.29

1.8

1.2

0.23

0.24

g/l

0.62

369

766

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

160

121

11.86

146.34

2.5

2.2

94.25

108.82

ug/min

0.07

(3002179) Metamyelocytes/Leukocytes in Blood

808

2687

2.84

145.94

4.0

3.5

0.70

0.86

1.03

257

779

(3022145) Colonoscopy Study observation

1154

4580

2.43

145.89

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

435

977

4.09

145.68

4.9

3.2

24.89

mmol/l

0.01

400

922

(40768804) Tissue Pathology biopsy report

3728

22804

1.85

144.66

2.4

2.0

—

(3017181) Myelocytes/Leukocytes in Blood

839

2870

2.76

143.61

4.2

3.5

0.91

1.10

0.98

256

833

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

423

941

4.13

143.45

2.3

1.8

1.47

2.07

ug/l

0.69

375

859

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

400

854

4.29

143.13

1.8

1.2

1.18

g/l

0.03

374

821

(3025159) Blasts/Leukocytes in Blood

822

2816

2.76

140.16

4.4

3.6

0.09

0.63

2.06

223

687

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

945

3481

2.58

139.56

3.7

2.3

—

(3021440) Promyelocytes/Leukocytes in Blood

806

2759

2.75

137.53

4.2

3.5

0.14

0.03

225

724

(3021901) Oxygen saturation in Capillary blood

248

361

6.21

136.22

3.0

2.2

90.92

91.57

0.77

241

351

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1782

8669

2.05

135.94

1.4

1.2

28.08

18.76

iu/ml

2.87

527

2435

(3029937) Albumin [Presence] in Urine by Test strip

2317

12471

1.91

131.30

4.6

2.7

0.00

estimate

0.02

845

4134

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6518

48506

2.19

130.86

6.8

3.2

38.87

36.06

mmol/mol

150.22

6099

45537

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1648

7891

2.07

130.59

1.4

1.2

13.15

2.23

u/ml

2.77

607

3259

(40758558) Short blood count panel - Blood

2530

14100

1.86

128.01

7.4

5.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

335

680

4.49

127.62

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1137

4779

2.28

124.76

2.6

7.24

8.52

umol/l

0.79

972

4229

(3028626) Oxygen [Partial pressure] in Capillary blood

309

609

4.61

122.01

4.4

3.4

8.33

8.84

kpa

4.90

299

590

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5205

36253

1.81

121.60

3.9

2.5

48.63

37.24

u/l

10.64

4890

34502

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6757

51398

2.28

121.39

20.5

8.5

83.09

84.75

ml/min/173m2

9.86

6373

45996

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

342

738

4.22

120.50

1.5

1.1

11.01

1.32

iu/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

320

668

4.35

117.63

1.6

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

469

1283

3.36

117.63

1.9

1.3

8.87

5.41

iu/ml

0.67

101

231

(3024980) IgG subclass 4 [Mass/volume] in Serum

269

489

4.98

116.80

1.6

1.4

0.64

0.82

g/l

1.96

200

384

(3018405) Lactate [Moles/volume] in Arterial blood

315

657

4.36

115.91

6.0

2.9

1.20

1.29

mmol/l

0.88

310

642

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

399

992

3.68

115.64

1.6

1.7

1.65

1.41

g/l

3.87

346

832

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1483

7125

2.03

114.75

3.5

2.3

0.82

1.04

e6/l

2.28

799

3413

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

348

795

3.99

113.60

1.8

1.5

—

(4062490) Immunoglobulin typing, IgG

199

279

6.41

113.25

1.7

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6678

50899

2.17

113.00

5.6

3.5

5.88

5.47

mmol/l

131.79

6163

47471

(1616796) Gas panel - Central venous blood

255

456

5.05

112.79

4.6

2.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

200

288

6.25

110.94

1.6

1.2

2.78

3.25

g/l

2.40

140

204

(3024139) IgG subclass 3 [Mass/volume] in Serum

200

289

6.22

110.57

1.6

1.2

0.37

0.46

g/l

0.85

141

201

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

725

2616

2.59

110.56

4.9

3.1

1.22

1.23

mmol/l

7.68

644

2218

(3042631) Mycobacterium sp identified in Specimen

216

338

5.76

110.30

3.2

2.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

200

290

6.20

110.20

1.6

1.2

6.36

6.82

g/l

0.86

140

205

(3024928) Oxygen saturation in Venous blood

260

494

4.76

107.20

3.6

64.38

61.45

1.06

246

486

(3000570) Elastase.pancreatic [Mass/mass] in Stool

357

868

3.75

106.77

1.4

1.3

301.93

283.07

ug/g

0.79

207

482

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

328

753

3.96

106.30

1.7

1.5

—

(4146454) Self-monitoring of blood glucose

100

15.09

104.98

2.9

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

238

427

5.03

104.85

2.8

1.8

16.46

17.14

2.12

231

419

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

509

1576

2.97

103.60

1.6

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

372

951

3.57

103.35

3.9

2.2

25.86

25.70

mmol/l

0.37

362

917

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

525

4.51

101.28

1.6

1.2

—

(3045414) Leukocytes [Presence] in Urine

876

3597

2.29

100.25

2.2

1.8

0.03

estimate

0.01

156

802

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

438

1273

3.15

99.32

2.1

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1366

6686

1.97

98.77

3.6

2.4

2.75

2.85

e6/l

0.13

670

2945

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

491

1538

2.93

97.79

2.0

2.2

38.08

41.94

u/l

4.05

437

1434

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

132

137

8.61

97.10

2.0

1.6

0.85

0.77

nmol/l

0.47

109

128

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3044

19066

1.67

95.24

4.2

2.5

0.29

0.36

estimate

0.10

738

3486

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

192

309

5.58

95.21

1.5

1.2

1.03

3.03

u/ml

1.61

177

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

212

376

5.07

94.60

1.7

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

277

618

4.05

93.24

2.2

1.8

132.98

132.68

g/l

0.06

194

449

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

217

402

4.86

92.12

1.2

1.1

292.50

163.10

titre

0.36

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

219

410

4.81

91.84

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

432

1314

3.00

90.52

1.2

3.71

0.54

u/ml

1.01

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

291

689

3.82

90.26

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

297

718

3.74

89.44

3.5

4.7

66.38

41.33

mg/l

0.57

248

652

(3011397) Hemoglobin [Presence] in Urine by Test strip

1890

10546

1.76

89.13

4.1

2.7

0.00

0.16

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

296

720

3.72

88.35

3.5

4.7

47.40

105.31

mg/l

0.45

246

649

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

906

3968

2.14

87.91

2.8

2.2

38.43

44.51

u/l

0.48

761

3417

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

373

1059

3.21

87.79

1.3

1.2

23.79

19.35

u/ml

0.13

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

348

947

3.34

87.70

2.6

0.90

1.01

g/l

0.14

298

834

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

255

561

4.10

87.44

1.6

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7265

58549

2.63

86.04

27.9

10.7

76.16

72.00

umol/l

22.70

7208

57693

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

390

1151

3.09

86.02

2.0

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

333

896

3.37

85.41

1.8

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

346

957

3.28

84.94

1.3

1.2

2.56

2.40

u/ml

0.06

(3045424) Erythrocytes [Presence] in Urine

510

1759

2.66

84.53

2.2

1.8

0.03

estimate

0.00

134

634

(3010838) Calcium [Moles/time] in 24 hour Urine

277

669

3.74

83.51

2.2

1.9

5.73

5.65

mmol/24h

0.07

241

613

(3023183) Ammonium ion [Moles/volume] in Plasma

210

412

4.58

83.27

2.7

2.5

34.86

36.68

umol/l

0.36

192

379

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

232

493

4.24

83.23

1.7

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

304

786

3.50

82.89

1.5

1.4

0.62

2.78

iu/ml

0.42

143

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

343

958

3.25

82.87

1.3

1.2

6.49

4.50

u/ml

0.18

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

971

4464

2.05

82.58

7.5

3.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

222

459

4.35

82.48

3.5

65.16

60.06

2.35

222

459

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

1095

3.09

82.38

2.5

7.38

6.99

g/l

3.32

337

1020

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

292

738

3.58

82.38

1.2

19.23

1.78

u/ml

0.72

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

371

1092

3.09

82.17

2.5

4.19

4.18

g/l

0.11

338

1017

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

362

1052

3.13

81.92

2.5

2.6

2.86

2.75

g/l

1.05

329

977

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1936

11111

1.71

81.43

1.8

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

368

1092

3.06

80.36

2.5

3.67

3.64

g/l

0.12

335

1017

(3012501) Base excess in Blood by calculation

218

458

4.28

79.36

5.1

2.6

2.94

2.39

mmol/l

1.80

159

297

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7207

58210

2.40

78.00

15.3

7.7

25.81

24.87

u/l

3.28

7035

56432

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1122

5529

1.92

77.91

5.2

3.9

32.81

31.88

1.98

812

3530

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

415

1348

2.81

77.07

1.4

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

120

8.09

76.57

1.2

1.1

47.07

9638.27

iu/ml

0.48

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1002

4780

1.97

76.45

1.8

1.4

1.49

1.23

19.12

863

4356

(3036489) Thrombin time

414

1352

2.79

76.10

2.1

1.9

21.26

20.51

1.31

369

1160

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

366

1118

2.97

75.96

6.0

3.7

1.60

1.55

0.40

335

1044

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

259

642

3.64

75.17

3.6

4.6

2.13

9.29

ratio

1.41

151

381

(36660697) Celiac disease serology panel - Serum

802

3560

2.10

74.53

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

164

287

5.11

74.28

2.1

1.5

1.66

1.70

mmol/l

0.15

159

280

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

178

335

4.76

74.18

6.5

5.1

11.48

11.24

mg/l

0.25

166

321

(3028707) Methadone [Presence] in Urine by Screen method

146

236

5.53

72.07

2.5

2.9

—

(3003181) Sodium [Moles/volume] in Urine

185

369

4.49

71.89

1.4

1.3

64.13

68.87

mmol/l

0.57

149

300

(3035715) Granulocytes [#/volume] in Blood

221

506

3.93

71.78

3.0

2.9

3.83

3.77

e9/l

0.16

221

506

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

357

1113

2.91

71.41

2.4

2.3

3.70

3.55

g/l

0.96

345

1058

(3047181) Lactate [Moles/volume] in Blood

297

834

3.22

71.07

6.5

4.1

1.25

1.15

mmol/l

1.32

254

730

(3017143) Hepatitis C virus Ab [Presence] in Serum

1013

4988

1.91

69.97

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

171

331

4.63

68.92

1.7

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

188

393

4.29

68.88

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

313

927

3.05

68.50

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

785

3591

2.03

66.94

2.6

2.4

16.27

21.05

au/ml

0.91

564

(3007930) Methemoglobin/Hemoglobin.total in Blood

335

1045

2.90

66.91

6.3

3.8

0.90

0.92

0.31

308

971

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

190

410

4.15

66.81

1.2

1.1

31.40

2.44

u/ml

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

736

3302

2.06

66.15

1.4

1.3

41.87

55.86

au/ml

1.10

257

(3025941) Bacteria identified in Stool by Culture

559

2250

2.28

66.05

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

717

3192

2.08

65.77

4.8

2.7

—

(3037756) Immunofixation for Serum or Plasma

199

450

3.97

65.74

1.6

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

176

363

4.34

65.60

1.8

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

12.83

65.49

1.8

1.3

93.46

88.45

umol/l

0.04

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

285

828

3.11

64.43

2.7

2.5

0.03

0.02

g/l

0.35

254

761

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

306

928

2.98

64.25

2.2

2.3

11.30

10.42

mg/l

1.26

283

882

(3030981) Hyaline casts [#/volume] in Urine by Automated count

679

2992

2.09

63.94

2.6

2.0

0.37

0.33

e6/l

0.21

643

2836

(3041096) Erythrocytes [Presence] in Urine by Automated

2248

14076

1.57

63.92

3.7

2.3

0.22

0.25

estimate

0.08

736

3414

(44790048) Parainfluenza type 2 nucleic acid detection

181

391

4.15

63.56

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

181

391

4.15

63.56

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

181

391

4.15

63.56

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

181

391

4.15

63.56

1.7

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

945

2.94

63.35

2.6

2.5

10.07

10.13

g/l

0.06

270

868

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4944

36658

1.52

63.06

3.6

3.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

231

603

3.44

62.03

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

231

603

3.44

62.03

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

2264

14317

1.55

61.05

3.0

2.2

0.07

0.03

0.26

246

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

150

289

4.64

60.81

1.3

1.1

34.50

11.00

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

271

794

3.08

60.38

2.6

0.01

0.00

g/l

0.70

235

716

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6424

50758

1.69

60.36

4.6

3.3

1.29

1.18

mmol/l

30.45

5915

47490

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

381

1345

2.57

59.96

2.2

2.1

4.77

16.52

iu/l

0.45

167

612

(3020191) Ethanol [Moles/volume] in Serum or Plasma

122

7.00

59.79

1.4

1.1

1.40

0.90

promille

1.91

101

(3019150) Specific gravity of Urine by Refractometry

1735

10369

1.61

59.37

4.3

2.7

1.02

1.17

kg/l

0.50

1214

6481

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

587

3.41

59.12

1.7

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

291

901

2.91

58.87

3.5

2.6

2.24

3.24

index

0.97

163

423

(3008295) Osmolality of Serum or Plasma

129

228

5.04

57.82

1.6

1.5

280.51

279.02

mosm/kgh2o

0.32

103

188

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

211

545

3.47

57.58

1.6

2.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

317

1043

2.75

57.31

1.7

1.3

0.31

0.27

mg/l

0.69

153

444

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

356

1250

2.58

56.62

2.4

2.0

93.82

95.05

0.42

342

1188

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

224

610

3.30

56.30

5.8

4.4

523.74

361.18

iu/ml

0.46

(46235355) HIV 1 and 2 tests - Meaningful Use set

1599

9486

1.61

55.95

2.0

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

428

1660

2.34

54.93

1.8

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

702

3318

1.95

54.07

3.1

2.2

67.54

75.72

ml/min/173m2

6.96

343

1186

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6808

55025

1.77

53.69

6.2

4.2

2.69

3.04

mmol/l

188.29

6356

51795

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

118

206

5.10

53.64

1.8

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

251

757

2.98

53.20

3.0

2.5

57.27

56.95

0.16

251

757

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

250

753

2.99

53.10

2.8

2.6

0.00

g/l

-0.00

235

716

(4035726) Immunohistochemistry procedure

927

4815

1.79

53.04

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

109

183

5.30

51.73

1.2

62.33

37.41

u/ml

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

139

289

4.29

51.33

1.4

1.2

—

37.91

—

(3049717) Cytology report of Urine Cyto stain

344

1248

2.49

51.09

2.6

2.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

274

887

2.78

51.07

1.2

1.3

102.59

239.68

titre

1.26

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

10.67

50.80

1.5

1.3

0.38

0.49

ug/l

0.81

(3039000) Anion gap in Blood by calculation

204

560

3.26

50.63

7.9

4.9

11.14

10.72

mmol/l

0.99

177

493

(3018572) Chloride [Moles/volume] in Blood

204

561

3.26

50.49

7.9

4.9

105.09

105.63

mmol/l

0.96

177

494

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

324

1149

2.55

50.46

2.4

2.2

189.49

175.45

1.95

314

1079

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

753

3732

1.86

50.06

1.3

1.2

120.82

158.57

u/ml

1.96

281

1563

(3004809) Band form neutrophils/Leukocytes in Blood

182

471

3.46

49.55

2.9

3.5

1.52

2.21

1.19

169

430

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

294

1004

2.64

49.42

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

267

870

2.76

49.16

1.2

853.33

1131.08

titre

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

6.68

49.08

5.4

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

295

1015

2.62

48.85

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

159

382

3.72

48.32

1.5

1.3

—

nmol/l

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3130

21888

1.43

48.26

2.0

1.7

1.36

1.27

mmol/l

7.34

2584

18996

(42529406) Shigella sp [Presence] in Stool by Culture

295

1023

2.60

48.08

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6724

54497

1.68

47.60

5.5

3.9

4.62

5.02

mmol/l

196.00

6293

51560

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

311

1115

2.51

47.34

3.4

4.0

1.43

1.15

mg/l

7.49

295

1053

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

240

757

2.85

46.95

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

458

1949

2.13

46.88

2.4

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6687

54231

1.65

45.69

5.4

3.8

1.47

1.57

mmol/l

68.37

6217

51101

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

175

466

3.36

45.60

1.5

1.3

0.61

0.59

nmol/l

0.45

167

455

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

177

475

3.33

45.57

1.5

1.3

0.27

0.20

nmol/l

0.19

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

143

334

3.82

45.24

1.6

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

159

403

3.52

44.69

1.9

1.7

23.21

28.26

mg/l

0.56

155

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

388

3.54

43.68

1.4

—

(3007461) Platelets [#/volume] in Blood

7366

61631

2.20

43.39

33.2

13.1

256.26

255.49

e9/l

0.48

7262

59984

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

132

302

3.89

42.99

1.6

1.7

—

(3017569) Oxygen content in Arterial blood

7.31

42.87

2.1

2.9

16.06

15.72

0.28

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

155

398

3.48

42.74

1.4

—

(3035941) MCH [Entitic mass]

7366

61673

2.18

42.52

33.0

13.0

30.28

30.27

0.22

7309

60926

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

152

387

3.50

42.45

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7366

61678

2.18

42.41

33.1

13.0

91.11

90.65

16.11

7310

60927

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7366

61683

2.18

42.31

34.1

13.2

40.17

41.82

8.55

7309

60894

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

251

856

2.63

42.31

1.2

1.1

64.70

34.33

u/ml

1.48

(3017354) Segmented neutrophils/Leukocytes in Blood

129

294

3.91

42.24

2.9

3.7

61.46

56.02

1.94

115

261

(3026361) Erythrocytes [#/volume] in Blood

7366

61689

2.18

42.19

33.2

13.1

4.46

4.55

e12/l

47.32

7248

59819

(3010813) Leukocytes [#/volume] in Blood

7367

61702

2.18

42.16

33.2

13.1

6.81

6.31

e9/l

68.01

7252

59803

(3000963) Hemoglobin [Mass/volume] in Blood

7366

61709

2.17

41.77

33.5

13.1

134.04

137.01

g/l

62.80

7311

60968

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

239

4.24

41.70

5.6

3.7

343.89

365.46

umol/l

0.65

200

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

154

401

3.43

41.57

1.4

1.3

0.18

0.17

nmol/l

0.50

124

328

(3013139) Helicobacter pylori Ag [Presence] in Stool

655

3289

1.82

41.46

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

128

297

3.84

40.90

3.3

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1301

7855

1.55

40.67

1.6

—

(4015189) Microbial culture of sputum

9.40

40.33

2.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

163

4.96

40.25

1.6

1.1

6.35

5.15

u/l

0.67

140

(3000475) Leukocytes [#/volume] in Synovial fluid

223

738

2.71

39.88

1.6

1.4

11957.60

12109.70

e6/l

0.02

156

507

(3004451) EKG impression Narrative

7.67

39.23

1.4

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

144

377

3.41

38.57

1.5

—

(3002256) Pathology report gross observation

1238

7475

1.54

38.48

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

144

378

3.40

38.42

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

399

1743

2.07

38.04

1.6

1.7

12.96

14.71

u/ml

0.22

597

(3021879) Hepatitis B virus core Ab [Presence] in Serum

679

3534

1.76

37.99

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

146

390

3.34

37.91

1.5

1.4

33.91

39.32

g/l

5.09

133

375

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

143

378

3.37

37.75

1.5

—

(3011985) Renin [Units/volume] in Plasma

158

448

3.15

37.26

1.7

69.97

67.17

mu/l

0.03

144

410

(3023199) Leukocytes [#/volume] in Pleural fluid

138

360

3.42

37.18

1.6

1.4

2353.63

3223.54

e6/l

0.71

106

251

(3048929) Epstein Barr virus Ab [Presence] in Serum

344

1436

2.16

36.90

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

890

5022

1.63

36.79

4.4

5.1

9.69

41.57

ug/l

3.47

740

3964

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

339

1409

2.17

36.76

1.2

3.64

4.00

0.38

293

(3040151) Glucose [Moles/volume] in Capillary blood

106

234

4.03

36.29

4.4

2.5

6.53

5.93

mmol/l

1.43

188

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

109

246

3.94

36.22

2.0

3.7

254.38

268.16

e6/l

0.19

213

(3020876) Protein [Mass/time] in 24 hour Urine

119

287

3.69

36.04

2.3

2.8

0.91

1.34

g/24h

0.76

166

(3011412) CD3 cells [#/volume] in Blood

132

344

3.42

35.64

1.8

3.1

1293.41

1202.02

e6/l

0.57

113

315

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

187

4.37

35.05

1.9

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

6.53

34.72

1.7

1.8

13.40

126.73

umol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

268

1040

2.31

34.28

1.3

1.4

488.74

518.47

mg/l

0.53

258

992

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

148

4.79

34.14

2.0

1.3

—

(21494755) Public health laboratory ask at order entry panel

543

7936

0.57

33.83

1.3

—

(3044927) Protein electrophoresis panel - Urine

185

4.32

33.82

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

104

242

3.82

33.16

1.8

3.6

530.81

553.81

e6/l

0.18

201

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

153

4.64

32.85

2.0

1.2

—

(4024509) Urine culture

395

1813

1.97

32.80

2.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

105

248

3.76

32.79

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

105

248

3.76

32.79

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

105

248

3.76

32.79

1.4

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

155

4.58

32.35

1.5

1.7

1.93

1.94

umol/l

0.02

143

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

144

423

3.03

32.04

1.4

310.90

487.00

pmol/l

1.14

128

379

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

120

316

3.38

31.92

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

164

522

2.80

31.63

3.1

2.5

5571.57

609.47

u/ml

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

195

4.10

31.63

1.2

1.1

15.86

13.82

nmol/l

—

(3037121) Protein [Mass/volume] in Urine

289

1199

2.16

31.49

3.6

4.0

266.50

316.23

mg/l

0.32

138

582

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

117

306

3.40

31.46

1.2

54.72

73.96

u/l

2.80

100

266

(3044242) Glucose [Moles/volume] in Arterial blood

5.87

31.37

1.9

2.0

7.52

6.94

mmol/l

0.72

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

4.68

31.18

2.0

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

535

2749

1.77

31.13

1.1

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

176

588

2.67

30.96

1.4

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

103

251

3.65

30.79

2.0

2.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

236

911

2.32

30.58

2.6

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

376

1745

1.94

30.22

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2011

13859

1.37

30.01

5.8

5.4

2.69

3.86

ug/l

1.12

1804

12835

(3006571) Granulocytes/Leukocytes in Synovial fluid

119

328

3.23

29.47

1.6

1.4

54.50

53.12

0.12

192

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

11.21

29.33

2.5

1.2

19.33

3.83

ug/min

—

(3016038) Potassium [Moles/volume] in Urine

146

4.49

29.30

1.2

1.3

33.13

36.90

mmol/l

0.64

135

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

203

747

2.43

29.29

1.3

286.65

232.06

u/ml

1.50

115

471

(3044290) Cell count panel - Cerebral spinal fluid

229

891

2.30

29.15

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

102

257

3.52

29.05

1.7

1.5

7.34

7.51

ug/l

0.05

237

(3028308) Erythrocytes [#/volume] in Pleural fluid

118

327

3.21

28.98

1.5

1.4

104911.93

38526.14

e6/l

0.64

191

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

241

3.61

28.93

2.6

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

229

895

2.29

28.85

1.4

40.06

25.83

e6/l

0.23

165

669

(3022621) pH of Urine by Test strip

655

3629

1.64

28.82

2.4

1.9

6.06

6.12

0.77

385

2292

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

149

4.40

28.58

1.3

1.2

115.31

110.66

0.59

137

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

231

911

2.27

28.50

1.5

804.28

1009.34

e6/l

0.20

184

714

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5748

46342

1.36

28.42

25.9

10.8

13.70

13.34

82.00

5681

45538

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

148

473

2.79

28.37

1.1

1.48

1.44

g/l

0.62

135

437

(40768443) Skin Pathology biopsy report

430

2129

1.82

28.29

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

180

3.99

27.57

1.1

87.73

73.23

u/l

0.42

160

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

188

3.92

27.53

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

7.55

27.45

2.7

2.4

742.70

635.95

0.61

(3000012) Reticulocyte production index

112

311

3.20

27.44

2.2

2.4

0.84

0.82

0.15

179

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.31

27.38

2.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

228

911

2.24

27.28

1.3

3.70

3.42

mmol/l

4.46

214

867

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

211

817

2.31

27.18

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

300

1336

2.01

27.13

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

179

3.96

26.98

1.1

29.65

17.49

u/l

0.36

159

(3017704) Immunofixation for Urine

100

5.13

26.86

1.4

2.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

100

264

3.36

26.56

1.4

1.2

329.72

709.61

u/l

2.05

259

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.45

26.20

2.2

1.5

955.00

414.44

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

103

280

3.27

26.13

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

7.10

26.09

1.3

7.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

272

3.30

26.01

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

272

3.30

26.01

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

105

290

3.22

25.97

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.25

25.65

2.1

1.2

64.76

1742.32

mg/l

0.50

(3002079) Sodium [Moles/time] in 24 hour Urine

140

4.30

25.58

1.2

165.25

159.99

mmol/24h

0.13

140

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

163

4.02

25.51

1.4

1.2

0.32

0.29

g/l

2.38

133

(4094501) Cardiovascular stress test using bicycle ergometer

259

1118

2.07

25.51

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

105

294

3.17

25.40

1.4

1.3

6.11

5.22

mmol/l

2.59

276

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

176

3.88

25.25

1.5

1.4

6.98

5.28

u/l

0.56

138

(3009214) Lutropin [Units/volume] in Serum or Plasma

312

1449

1.93

25.03

1.4

13.01

11.08

u/l

1.17

248

1172

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

128

4.43

24.97

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

104

295

3.13

24.64

1.5

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

144

489

2.62

24.61

2.0

1.7

351.95

345.81

mu/l

0.07

117

390

(40759836) Histone Ab [Presence] in Serum by Immunoblot

275

3.20

24.28

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

454

2393

1.71

24.06

1.2

1.1

581.54

196.58

titre

0.77

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

259

3.25

24.02

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

183

3.73

23.94

1.9

1.5

80.59

80.06

ng/l

0.02

183

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.85

23.69

1.3

1.1

1.49

2.17

iu/ml

1.00

(3014271) Vancomycin [Susceptibility]

5.65

23.62

3.0

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

323

2.97

23.41

3.0

3.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

233

1002

2.08

23.20

1.2

1.1

15.92

13.58

au/ml

0.23

342

(3044941) Cell count panel - Synovial fluid

153

552

2.47

23.11

1.4

1.3

—

(1002224) Polysomnography panel

477

2586

1.66

22.75

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

111

344

2.87

22.60

3.5

2.6

13.90

14.04

index

0.05

184

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

280

1299

1.93

22.56

1.3

—

(3016750) Collection duration of Urine

6.91

22.39

2.7

2.5

478.48

503.32

min

0.49

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

529

2.47

22.34

1.3

1.4

37.59

29.29

u/l

0.28

124

453

(21494890) Protein electrophoresis panel - 24 hour Urine

232

3.29

22.14

2.5

2.7

—

(3012565) Volume of 24 hour Urine

137

4.07

22.13

1.7

2.3

2063.02

2111.08

0.11

132

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.91

22.11

1.5

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

148

539

2.44

21.93

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

188

765

2.19

21.59

1.5

1.3

118.07

148.32

au/ml

2.72

257

(44813793) Dust mix specific IgE antibody measurement

107

335

2.84

21.40

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

265

3.08

21.30

1.3

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.33

21.28

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

134

474

2.51

21.13

1.1

—

16.19

—

(40768806) Pleura Pathology biopsy report

110

353

2.77

21.03

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

729

9032

0.68

20.94

1.9

3.37

3.42

ratio

0.54

557

6874

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

330

2.82

20.87

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

253

3.08

20.46

1.4

1.3

134951.21

78935.14

e6/l

0.23

167

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

179

3.51

20.32

1.1

11.62

8.34

u/ml

0.29

(3008898) HLA-B27 [Presence]

343

1753

1.75

20.29

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.97

20.20

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

293

2.91

20.13

1.3

1.2

1.94

2.05

mmol/l

0.44

277

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

248

3.07

19.90

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

296

2.88

19.78

1.2

—

titre

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

111

370

2.66

19.76

1.2

38.62

44.73

mg/l

0.78

306

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

3.51

19.75

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

255

3.02

19.59

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

266

1272

1.87

19.58

1.1

1.82

5.43

eliau/ml

2.70

246

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

124

439

2.51

19.56

1.1

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

251

3.04

19.51

1.3

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

257

3.00

19.34

1.1

280.97

290.32

mg/l

0.70

239

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

153

3.64

19.06

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

149

3.68

19.04

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

309

2.78

18.85

1.3

1.1

109.13

120.89

pmol/l

1.44

309

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

529

6846

0.66

18.81

1.7

1.6

3.47

3.60

mmol/l

1.73

365

4616

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

121

435

2.47

18.50

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

143

556

2.29

18.37

1.3

1.2

4.03

3.82

u/ml

0.06

249

(3017446) Testosterone [Moles/volume] in Serum or Plasma

678

4178

1.47

18.30

2.5

2.0

12.28

14.10

nmol/l

6.13

579

3889

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.72

18.27

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

5.72

18.27

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.72

18.27

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.72

18.27

1.2

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

213

971

1.96

18.13

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

149

594

2.23

18.05

1.3

1.2

2.92

2.97

u/ml

0.02

205

(3035947) Staphylolysin Ab [Units/volume] in Serum

135

3.73

17.89

1.1

1.0

2.80

2.78

iu/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

222

3.07

17.87

1.3

1.2

185.00

68.00

titre

0.69

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

4.28

17.72

1.6

1.4

14.06

13.97

pmol/l

0.05

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

136

3.71

17.71

1.7

1.8

2.55

2.08

nmol/l

0.26

105

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

242

2.97

17.69

1.2

1.1

—

(4195642) Thrombophilia screening test

149

601

2.20

17.56

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

193

3.21

17.49

2.9

2.6

22.12

16.22

mu/l

0.88

182

(3033099) Centromere Ab [Titer] in Serum

4.64

17.45

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.70

17.32

25.3

32.9

114.85

123.90

ug/l

0.33

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.32

17.17

2.4

2.7

0.63

mmol/l

0.09

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

892

5845

1.39

17.08

2.2

1.9

—

(3042733) HLA Ab [Presence] in Serum

6.68

16.92

4.9

3.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

103

361

2.53

16.65

1.1

262.48

264.71

mg/l

0.04

319

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

6.24

16.48

2.2

1.3

9.67

10.66

mg/l

0.36

(3026051) Granulocytes/Leukocytes in Pleural fluid

5.39

16.24

1.6

1.3

23.84

22.35

0.08

(3032057) Clostridioides difficile [Presence] in Stool

6.09

16.11

1.6

2.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

4.42

16.09

1.6

1.2

58.78

62.18

0.18

(1001926) Buprenorphine [Presence] in Urine by Screen method

245

1221

1.79

15.85

2.0

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

268

2.74

15.79

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

276

1428

1.73

15.69

1.2

1.1

1.65

1.97

u/ml

0.20

171

741

(3038071) Oxygen [Partial pressure] in Mixed venous blood

15.30

15.65

16.1

8.1

5.20

4.84

kpa

0.85

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

155

669

2.06

15.42

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

117

3.70

15.26

1.7

3.0

0.18

0.27

e9/l

0.60

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

105

3.87

15.24

1.2

2.1

40.26

41.96

g/l

1.01

105

(3003329) Lymphocytes/Leukocytes in Synovial fluid

230

2.85

15.12

1.7

1.4

41.16

39.75

0.10

129

(3020911) Cortisol [Moles/time] in 24 hour Urine

102

3.90

15.06

1.6

1.4

73.38

241.23

nmol/24h

0.96

102

(3036670) Protein [Mass/volume] in Synovial fluid

4.16

14.96

1.2

41.01

39.63

g/l

0.21

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

776

1.96

14.82

1.1

2.74

3.07

0.11

180

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

900

1.89

14.81

3.8

4.1

110.07

968.31

u/ml

1.39

162

818

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1582

11459

1.27

14.78

4.7

4.2

21.19

21.13

0.05

747

5516

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

150

3.30

14.71

1.7

1.8

29.99

28.76

umol/l

0.47

139

(3003694) ABO and Rh group [Type] in Blood

2157

16206

1.24

14.58

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

240

2.77

14.55

2.5

2.9

40.29

39.14

0.20

119

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

184

863

1.90

14.48

1.5

1.3

28.40

31.92

u/l

0.67

149

716

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

246

2.73

14.43

1.0

1.1

1.22

1.14

u/l

0.15

107

(37021550) Renin [Units/volume] in Plasma --upright

5.44

14.43

1.3

1.6

45.24

57.57

mu/l

0.20

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

141

604

2.07

14.34

1.2

1.1

117.95

116.86

0.14

131

539

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

3.17

14.26

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

111

3.66

14.13

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

111

3.66

14.13

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

313

1723

1.62

14.10

3.5

4.3

324.16

2144.53

u/ml

2.26

267

1495

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.67

14.00

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

957

6535

1.33

13.90

2.3

2.0

—

(3042517) Benzodiazepines panel - Urine

27.92

13.86

1.5

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

638

2.02

13.74

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

101

3.76

13.73

3.3

3.1

28.01

26.61

umol/l

0.35

(3035880) pH of Pleural fluid

139

3.31

13.73

1.4

1.2

7.38

7.39

0.09

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

6.54

13.66

3.7

1.1

7.05

5.99

mmol/l

0.76

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.23

13.62

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

147

656

1.99

13.40

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

232

2.71

13.28

1.3

1.5

26.20

21.19

u/ml

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.80

13.27

1.8

3.2

14.97

17.38

umol/l

0.34

(4268621) Lupus anticoagulant assay

106

419

2.24

13.23

2.4

2.2

—

(3023410) Appearance of Cerebral spinal fluid

110

443

2.20

13.13

1.7

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

229

2.70

13.07

1.3

1.4

4.25

4.99

umol/l

0.84

200

(3021387) Prolactin [Units/volume] in Serum or Plasma

318

1792

1.59

13.03

1.7

328.86

266.75

mu/l

1.83

289

1631

(3028433) Virus identified in Specimen by Culture

3.80

12.97

1.2

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

269

2.53

12.64

1.2

1.3

0.51

0.70

ratio

3.21

148

(3047007) Chlamydophila sp Ab [Presence] in Serum

177

858

1.83

12.62

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

5.07

12.47

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

4.48

12.46

1.3

1.1

7.70

11.60

mmol/l

1.84

(3004716) Salmonella sp identified in Stool by Organism specific culture

422

2562

1.48

12.26

1.3

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

475

2.11

12.15

2.4

2.6

25.47

20.40

iu/ml

0.20

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

146

3.09

12.10

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

189

2.81

12.05

1.6

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

345

2.28

11.68

2.2

3.2

18.39

19.22

nmol/l

0.32

337

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

127

3.20

11.59

1.0

1.1

—

(4198724) Urine methamphetamine measurement

4.88

11.53

1.4

6.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

189

2.76

11.51

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

189

2.76

11.51

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

189

2.76

11.51

1.6

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

104

433

2.13

11.48

1.1

12.87

8.06

iu/ml

0.95

137

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

205

1068

1.71

11.47

2.0

1.7

192.92

212.67

pmol/l

1.94

189

1026

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

106

445

2.11

11.46

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

286

1622

1.57

11.44

1.9

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

208

2969

0.61

11.39

1.1

0.57

0.62

ratio

0.71

358

(3000034) Microalbumin [Mass/volume] in Urine

161

2.91

11.38

3.3

1.7

45.29

13.58

mg/l

0.75

(3008037) Lactate [Moles/volume] in Venous blood

129

584

1.96

11.36

3.2

2.1

1.44

1.34

mmol/l

0.64

120

569

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

264

1473

1.60

11.32

1.9

1.7

43.08

44.38

nmol/l

0.28

257

1447

(3034891) Synovial lining cells/cells in Synovial fluid

129

3.15

11.31

1.5

1.4

3.20

2.32

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.77

11.27

1.4

1.2

419.98

150.09

ug/l

0.37

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

1.27

1.04

mg/l

0.19

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

3.66

3.54

mg/l

0.02

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

1.20

2.50

mg/l

0.54

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

1.90

4.29

mg/l

0.74

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

1.20

1.29

mg/l

0.07

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.22

11.17

1.7

1.5

1.53

1.28

mg/l

0.18

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

286

2.38

11.15

2.0

1.8

4.49

3.36

mg/l

0.77

279

(3036603) Volume of Urine

249

2.49

11.12

1.6

1.7

2330.81

1982.22

0.49

243

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

106

451

2.08

11.08

1.2

1.1

93.64

97.57

0.75

101

410

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.68

11.01

1.3

1.4

287.19

365.55

pmol/l

0.43

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.26

10.99

2.4

1.5

5.07

4.84

kpa

0.36

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.26

10.99

2.4

1.5

10.61

10.77

kpa

0.08

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.29

10.83

1.6

1.0

0.34

0.68

iu/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

313

2.29

10.74

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.07

10.65

1.6

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.24

10.56

2.0

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.50

10.51

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.59

10.37

1.1

0.76

0.63

umol/24h

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

17.63

10.35

2.2

1.1

49.25

46.25

umol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

218

1191

1.63

10.23

1.2

1.1

1.42

1.57

u/ml

0.08

122

554

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.89

10.12

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

4.33

10.05

1.1

1.2

9.56

6.91

pmol/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

196

1052

1.66

9.87

1.2

1.1

5.51

3.93

u/ml

0.22

108

486

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

748

1.78

9.85

1.2

0.53

1.21

1.66

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

11.33

9.79

11.7

3.4

4.91

6.75

mmol/l

0.99

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.32

9.66

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

267

2.32

9.61

1.0

1.1

—

0.62

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

172

2.67

9.61

1.1

1.0

7.54

12.12

u/ml

1.11

123

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

16.52

9.53

6.2

12.6

11.67

9.94

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

431

2.01

9.44

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

127

610

1.85

9.44

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.60

9.40

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

188

1013

1.65

9.35

1.2

1.1

2.75

4.22

u/ml

0.94

429

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

130

634

1.82

9.21

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

504

1.92

9.12

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

253

2.31

8.99

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

148

2.74

8.98

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

148

2.74

8.98

1.3

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

218

1233

1.57

8.91

1.2

1.1

5.03

4.70

u/ml

0.10

122

650

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

175

2.57

8.80

1.9

1.3

—

(40768446) Kidney Pathology biopsy report

3.36

8.80

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.89

8.79

1.1

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

150

2.71

8.77

1.1

1.50

6.88

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

334

2075

1.43

8.68

2.2

4865.70

5469.24

u/l

0.13

110

902

(3024869) Neuronal Ab [Presence] in Serum

4.22

8.66

1.1

—

(3024932) HLA-DR beta [Type]

3.72

8.61

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

259

2.25

8.53

1.3

1.2

77.88

76.96

umol/l

0.09

259

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

3.05

8.51

1.3

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

211

1198

1.56

8.50

1.2

1.1

0.52

1.09

u/ml

1.59

519

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.31

8.49

1.1

1.0

1.17

1.18

mmol/l

0.31

(3018133) Calcium [Moles/volume] in Urine

3.12

8.35

1.8

2.1

2.89

2.59

mmol/l

0.28

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

191

2.45

8.29

1.8

1.6

3.06

4.35

u/field

0.35

128

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

167

2.54

8.09

1.3

70.60

75.46

u/l

0.16

138

(3024471) HLA-A [Type]

3.55

8.08

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

4.13

8.05

1.0

1.1

—

u/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

189

2.43

8.01

1.2

1.1

133.72

276.36

ng/l

0.64

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

7.93

1.6

0.0

27.31

—

mg/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

308

2.10

7.93

1.2

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.45

7.75

1.0

0.01

0.13

u/ml

0.48

(3023511) Choriogonadotropin [Units/volume] in Urine

171

946

1.60

7.73

1.4

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

4.30

7.71

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

146

2.60

7.63

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

146

2.60

7.63

1.7

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.41

7.55

1.3

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

152

2.56

7.54

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

147

2.58

7.53

1.7

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

132

2.67

7.50

1.1

91.63

91.89

0.02

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

179

2.42

7.49

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.65

7.47

1.3

3.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

164

2.48

7.40

1.3

15.32

19.77

u/l

0.28

133

(3000764) Benzodiazepines [Presence] in Urine

291

1818

1.42

7.39

1.9

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.50

7.34

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

116

591

1.74

7.20

1.2

—

(3047189) Immunofixation for 24 hour Urine

130

2.65

7.19

2.1

2.2

—

(44806420) Estimation of glomerular filtration rate

115

585

1.74

7.18

3.0

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

321

2.01

7.14

2.1

1.6

—

(3027008) Opiates [Presence] in Urine

293

1847

1.41

7.09

1.9

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.86

7.06

1.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

293

1849

1.41

7.05

1.9

1.5

—

(3006270) Folate [Moles/volume] in Blood

287

2.06

7.04

1.1

394.09

385.67

nmol/l

0.12

265

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

6.10

6.98

1.1

0.03

u/ml

0.02

(3001964) Herpes simplex virus Ag [Presence] in Specimen

112

2.76

6.98

1.5

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

6.94

1.4

0.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.29

6.93

8.0

2.9

93.14

38.84

pmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

133

2.59

6.89

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

8.81

6.88

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.09

6.80

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

414

1.86

6.78

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

129

2.60

6.78

1.1

90.24

91.55

0.07

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.17

6.71

1.2

0.53

1.91

mmol/l

0.57

(37208534) Antinuclear antibody arbitrary concentration in serum

130

2.58

6.68

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.71

6.67

1.4

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

125

2.61

6.67

1.2

—

(40757373) Influenza virus identified in Isolate

3.75

6.50

1.5

1.4

—

(3034426) Prothrombin time (PT)

112

2.68

6.44

1.2

1.1

28.12

27.47

0.36

112

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

2.65

6.34

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

297

1915

1.38

6.33

3.3

2.4

1.02

ratio

0.25

256

1693

(3020491) Glucose [Moles/volume] in Blood

246

2.08

6.30

1.9

1.3

6.88

5.74

mmol/l

1.50

188

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.06

6.23

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

6.61

6.23

9.3

10.5

62.90

68.42

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

265

3186

0.72

6.23

1.5

1.6

1007.23

1037.71

mu/l

0.25

217

2706

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

2.15

6.23

1.1

1.08

1.05

ratio

0.92

179

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

123

670

1.62

6.02

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

158

916

1.53

5.93

1.2

1.0

0.15

0.30

u/ml

0.71

259

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.58

5.92

32.2

2.9

100.40

99.14

g/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.94

5.91

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1182

9041

1.18

5.91

3.3

3.1

0.70

0.77

ug/l

2.60

756

5484

(3027944) Amphetamines [Presence] in Urine

284

1841

1.37

5.89

1.7

1.5

—

(3014891) Appearance of Pleural fluid

5.17

5.88

2.5

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

9.69

5.78

1.0

0.04

u/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

168

2.26

5.74

2.0

2.4

41.70

51.80

umol/l

1.95

155

(3011897) Casein IgE Ab [Units/volume] in Serum

109

2.59

5.72

1.0

1.6

0.09

2.56

u/ml

1.54

109

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

476

3334

1.27

5.70

2.0

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

299

1.92

5.68

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.80

5.60

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.83

5.58

6.3

5.9

68.92

25.26

ug/min

0.96

(3038515) Glucose [Moles/volume] in Venous blood

514

1.69

5.58

3.5

2.0

7.19

6.30

mmol/l

2.70

503

(3045142) Bone marrow Pathology biopsy report

482

1.71

5.53

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

259

1.98

5.53

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.90

5.52

1.0

—

(1761868) Lipid panel - Serum or Plasma

2674

25336

0.89

5.36

3.1

2.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.14

5.29

1.4

1.1

0.62

0.73

mg/l

0.23

(3002523) Influenza virus A Ag [Presence] in Specimen

196

1217

1.43

5.27

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

136

2.33

5.22

1.1

2.72

23.64

u/ml

0.67

(3003740) Influenza virus B Ag [Presence] in Specimen

196

1220

1.42

5.20

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

5.17

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.61

5.10

1.0

7.67

20.25

u/l

0.56

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.61

5.10

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

144

2.27

5.03

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

122

2.39

5.03

1.1

1.3

3.40

17.58

—

(40768795) Lymph node Pathology biopsy report

103

564

1.61

5.01

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

976

7447

1.18

5.01

1.6

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

+∞

4.96

1.0

0.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.72

4.90

1.1

1.3

—

(4034850) Laboratory test

210

1340

1.39

4.86

11.7

5.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.40

4.86

1.3

1.4

92.83

81.47

ng/l

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.63

4.85

1.3

1.2

146.84

148.83

nmol/l

0.02

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

6.92

4.85

1.4

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.71

4.74

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.49

4.70

1.1

—

(40768441) Liver Pathology biopsy report

314

1.80

4.66

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

239

1.92

4.63

2.1

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

8.81

4.61

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

407

1.69

4.60

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

106

2.41

4.55

1.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

562

4118

1.22

4.53

2.1

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

112

2.36

4.50

1.0

1.1

0.44

6.27

u/ml

0.91

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

255

1.87

4.45

1.9

1.6

1.79

1.88

u/field

0.04

132

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.61

4.43

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

2.34

4.42

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

182

2.04

4.42

1.1

90.43

92.40

0.17

149

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1171

0.63

4.38

1.6

1.5

63.56

62.91

ug/l

0.05

1171

(3019832) Treponema pallidum Ab [Presence] in Serum

770

5835

1.18

4.30

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.70

4.29

2.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

220

1451

1.34

4.20

2.0

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

299

2059

1.29

4.19

1.4

1.3

248.50

227.06

miu/ml

0.39

125

1114

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.38

4.13

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

7.83

3.91

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

155

2.05

3.89

1.8

2.1

32.31

30.87

0.21

155

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.85

3.88

1.4

1.3

42.75

72.80

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

242

1.82

3.86

1.1

1445.66

1411.99

miu/ml

0.08

242

(3035320) C reactive protein [Mass/volume] in Body fluid

341

1.68

3.82

3.8

2.2

26.06

31.53

mg/l

0.71

232

(3048879) Bone marrow aspiration report

2.52

3.81

1.7

2.7

—

2.00

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.00

3.80

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

157

2.02

3.77

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

116

1464

0.69

3.77

1.5

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

225

1.84

3.77

1.2

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

493

1.56

3.77

1.1

17.45

18.42

u/ml

0.11

227

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.63

3.66

1.2

1.1

—

(3024263) Appearance of Synovial fluid

141

2.06

3.66

1.8

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.73

3.65

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

160

1.98

3.60

3.7

2.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

6.40

3.50

1.0

0.72

2.05

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

178

2069

0.75

3.49

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.08

3.48

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

132

2.07

3.48

2.4

2.9

1.10

1.34

0.34

132

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

251

1.76

3.47

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

129

807

1.41

3.47

1.1

1.73

3.96

eliau/ml

3.67

486

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

109

2.18

3.46

1.0

1.3

2.20

18.25

u/ml

0.96

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.70

3.45

4.0

4.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.58

3.39

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

360

1.62

3.39

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.01

3.35

1.4

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.01

3.35

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.95

3.27

1.2

1.0

—

(44806071) Cardiolipin IgM antibody measurement

3.09

3.26

1.0

—

(3020650) Glucose [Presence] in Urine

173

1.89

3.23

1.9

1.4

0.00

estimate

-0.00

173

(3047352) Trisomy 18 risk [Likelihood] in Fetus

117

1429

0.72

3.21

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

112

694

1.43

3.20

2.3

2.5

5.09

6.16

umol/l

0.59

537

(3005033) Fetal Nuchal fold Thickness US

115

1405

0.72

3.16

1.5

1.28

1.26

0.16

1032

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.01

3.13

1.9

1.3

6.63

14.17

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.48

3.06

1.0

1.1

0.00

6.62

u/ml

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.16

3.05

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.35

3.05

1.6

1.2

21.93

48.36

2.88

(4211845) Urine protein measurement

177

1.84

3.04

3.9

2.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

172

1.85

2.97

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

161

1074

1.33

2.96

1.5

1.4

0.30

0.42

nmol/l

1.83

113

822

(3038177) Helicobacter pylori Ab [Presence] in Serum

146

960

1.34

2.96

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

487

3681

1.17

2.88

1.4

26.80

31.61

iu/l

2.59

424

3236

(3041672) Baker's yeast Ab [Presence] in Serum

4.70

2.85

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

2.09

2.83

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.52

2.82

1.0

0.01

0.06

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.52

2.82

2.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.60

2.79

1.2

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.68

2.78

1.2

1.8

1.35

1.34

umol/l

0.06

(3043410) Blood group antigens tested for on Red Blood Cells

2.15

2.78

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

2.76

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.96

2.75

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.23

2.67

1.1

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

3.77

2.63

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

4.14

2.59

2.1

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.74

2.57

1.1

3.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.66

2.56

2.4

3.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.78

2.55

1.1

0.49

1.11

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

3.03

2.49

1.1

1.2

62.27

63.38

ug/l

0.06

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.35

2.48

1.0

1.1

0.35

0.75

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.91

2.47

3.3

7.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.60

2.46

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.71

2.45

1.2

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

279

1.58

2.44

1.0

843.68

694.36

ng/l

1.21

201

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

279

1.58

2.44

1.0

320.75

507.26

ng/l

0.81

211

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.45

2.42

1.4

1.5

—

(21494434) Karyotype in Bone marrow

329

1.53

2.40

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.47

2.40

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

281

1.57

2.37

1.0

48.20

47.64

ng/l

0.03

209

(3051101) Glucose [Moles/volume] in Cord blood

3.71

2.36

4.1

1.1

9.54

6.08

mmol/l

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.85

2.33

1.1

1.2

7.86

5.83

mmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

907

0.71

2.32

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.11

2.31

1.1

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.80

2.29

2.0

2.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

163

1796

0.79

2.23

1.5

66.83

63.87

ug/l

0.33

136

1490

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.99

2.22

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.02

2.21

1.9

1.5

7.48

8.79

ug/l

1.28

(40762814) Titanium [Mass/volume] in Blood

2.28

2.19

2.6

2.7

3.69

3.86

ug/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

135

1517

0.78

2.19

1.6

—

(4212803) Bone marrow aspirate examination

3.35

2.15

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.40

2.15

1.2

1.1

259.06

322.58

nmol/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.95

2.10

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.95

2.10

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.95

2.10

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.17

2.10

1.0

1.2

0.17

5.56

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.17

2.10

1.0

1.1

0.01

1.47

u/ml

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

127

1.80

2.08

1.3

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.75

2.08

1.1

1.59

1.41

umol/24h

—

(3009871) Measles virus Ab [Titer] in Serum

187

1.65

2.07

1.5

1.7

4697.14

2796.92

titre

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.46

2.06

3.0

1.6

0.58

0.95

u/field

0.67

(3046861) Legionella sp Ag [Presence] in Urine

4.06

2.02

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

4.89

2.00

1.0

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.40

1.97

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.97

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

219

1.57

1.91

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.07

1.90

3.1

3.0

8.31

38.79

ug/l

0.54

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.24

1.88

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

301

1.46

1.80

1.3

1.2

10.10

9.08

mm/h

0.29

301

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.82

1.80

1.1

—

(40765096) Chromosome analysis panel by Banding

127

1.73

1.80

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

216

1.55

1.79

2.2

1.54

2.66

ug/l

2.23

182

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.08

1.79

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.97

1.79

1.9

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.01

1.78

1.0

1.2

0.01

4.88

u/ml

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

158

1695

0.82

1.76

1.4

1.5

0.96

0.95

ratio

0.20

1031

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

158

1695

0.82

1.76

1.4

1.5

1.11

1.17

ratio

0.47

1038

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

158

1693

0.82

1.75

1.4

1.5

1.15

1.16

ratio

0.05

1028

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.71

1.72

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

109

1.78

1.72

1.2

1.4

13256.54

4732.93

e6/l

0.37

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

297

1.45

1.72

1.9

1.7

4.17

2.95

u/ml

0.26

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.93

1.70

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.12

1.65

1.0

1.1

0.14

0.60

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

547

0.69

1.65

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

157

1672

0.82

1.65

1.4

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

2.80

1.62

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

125

1.69

1.61

1.3

1.5

500.75

1432.33

e6/l

1.54

(3022725) Serotonin [Moles/volume] in Serum

3.11

1.61

1.5

542.83

1628.24

nmol/l

—

(3044007) Cell count panel - Peritoneal fluid

120

1.69

1.54

1.2

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

447

3532

1.12

1.52

2.7

4.1

42.75

56.79

u/ml

0.61

429

3438

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

272

2742

0.87

1.51

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

184

1.53

1.48

1.7

1.4

0.50

e9/l

0.04

184

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.57

1.47

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.57

1.47

2.7

2.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

295

2279

1.14

1.45

2.0

1.4

3.93

3.92

mg/l

0.01

227

1468

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

200

1.50

1.43

1.2

1.3

850.00

918.42

titre

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

129

931

1.22

1.42

1.7

1.6

—

(4038314) Semen analysis, post vasectomy

2.46

1.40

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

333

1.38

1.40

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.20

1.40

1.2

1.1

118.40

103.20

titre

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

423

0.68

1.37

1.6

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.93

1.33

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.43

1.31

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

234

1.43

1.29

1.9

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.27

1.25

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.75

1.25

1.4

1.5

1.34

1.18

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.92

1.22

1.7

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.98

1.21

1.1

6.52

5.44

mmol/l

2.67

(3044009) aPTT.lupus sensitive (LA screen)

2.28

1.11

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

122

0.50

1.10

1.0

1.2

55.29

71.78

ug/l

—

122

(3050794) Legionella sp Ab [Presence] in Serum

2.20

1.08

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.32

1.04

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

436

1.25

0.95

1.1

1.2

0.43

2.51

u/ml

2.11

117

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

214

1.36

0.90

1.1

1.2

60.55

62.94

u/ml

0.07

209

(3051387) C reactive protein [Mass/volume] in Capillary blood

131

996

1.16

0.90

4.8

2.4

22.02

27.06

mg/l

0.84

635

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.11

0.90

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.76

0.90

1.0

1.1

0.01

0.15

u/ml

1.25

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.57

0.88

1.6

2.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.03

0.87

1.2

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

156

1.41

0.86

1.1

43.82

33.69

iu/ml

0.26

156

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

122

0.58

0.83

3.0

5.7

9.75

8.35

—

122

(40761995) Spermatozoa Progressive [#/volume] in Semen

123

0.57

0.83

1.6

2.9

55.37

43.36

—

123

(3019174) dRVVT (LA screen)

1.89

0.82

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.89

0.82

1.3

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.72

0.76

2.2

4.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.72

0.76

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

161

1.37

0.74

3.2

3.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.00

0.72

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.58

0.71

1.9

4.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.91

0.70

1.0

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.91

0.70

1.0

1.2

0.01

0.49

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.91

0.70

10.2

8.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.55

0.69

1.1

2.2

5.50

3.73

nmol/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

191

1523

1.11

0.68

1.3

1.5

103.31

119.28

pmol/l

0.45

182

1487

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.66

0.68

1.0

8.62

8.34

mmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.83

0.67

1.8

2.5

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

101

1012

0.88

0.64

3.8

2.1

13.17

13.13

0.15

101

996

(3017509) Phencyclidine [Presence] in Urine

1.58

0.64

1.3

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.56

0.62

1.4

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

1.69

0.62

1.8

1.2

206.60

228.23

umol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.56

0.60

1.5

1.0

—

(4281824) Cell count and differential, peritoneal fluid

740

0.87

0.57

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.65

0.56

1.0

1.1

—

(40768793) Breast Pathology biopsy report

205

1661

1.09

0.56

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.40

0.54

1.1

12.66

10.75

u/ml

0.12

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.43

0.46

1.0

—

(3025130) Human papilloma virus identified in Specimen

140

1130

1.09

0.45

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

286

1.17

0.38

7.1

6.9

48.22

11947.29

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

186

0.80

0.34

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

397

1.13

0.34

1.5

1.3

165.27

187.98

pmol/l

0.72

397

(4133840) Spirometry

127

1.25

0.34

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

804

1.08

0.32

5.0

2.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.34

0.31

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

683

1.08

0.27

1.3

7.12

6.34

mmol/l

1.97

606

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

150

0.82

0.25

3.3

81.02

106.52

ng/l

—

(3022475) Manganese [Moles/volume] in Blood

1.29

0.23

1.8

1.3

0.17

0.16

umol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

444

1.09

0.22

1.2

1.1

0.91

2.39

u/ml

1.36

100

(3010937) Rubella virus Ab [Presence] in Serum

1.26

0.22

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.73

0.22

1.4

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1260

11246

0.98

0.22

1.5

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

8.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

423

1.08

0.19

1.1

0.24

3.38

u/ml

0.91

(3045462) Protein/Creatinine [Ratio] in Urine

1.24

0.19

3.6

6.2

32.10

37.77

mg/mmol

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.15

3.8

2.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

431

3718

1.02

0.15

1.8

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5603

49161

1.01

0.13

27.2

10.9

331.93

333.02

g/l

17.00

5571

48834

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

247

2128

1.02

0.11

1.5

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

297

1.07

0.11

2.0

1.7

144.67

2461.51

pmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.06

0.08

1.1

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

259

2245

1.02

0.07

1.5

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.87

0.07

22.0

4.8

0.26

0.19

—

(40758292) HTLV I+II Ab panel - Serum

105

0.92

0.04

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

140

0.94

0.03

1.3

—

(40768800) Prostate Pathology biopsy report

130

1141

1.00

0.00

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

101

890

1.00

0.00

1.4

3.62

3.65

ug/l

0.01

770

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

155.14

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.85

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint VOCALCORDDYS and mortality.

Females

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.737 [1.58, 1.91]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.223

During the follow-up period (1.1.1998 — 31.12.2019), 3227 out of 21177 females with VOCALCORDDYS died.

Males

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.823 [1.66, 2.0]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 3762 out of 15769 males with VOCALCORDDYS died.

Mortality risk

Mortality risk for people of age

years, who have VOCALCORDDYS.

N-year risk	Females	Males
1	0.158%	0.418%
5	1.028%	2.325%
10	2.726%	5.509%
15	4.727%	10.609%
20	8.034%	17.177%

Relationships between endpoints

↥

Index endpoint: VOCALCORDDYS – Vocal cord dysfunction

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vocal cord dysfunction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints